<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>c05836exv2w1.htm
<DESCRIPTION>AGREEMENT AND PLAN OF MERGER
<TEXT>
<HTML>
<HEAD>
<TITLE>exv2w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>&#091;EXECUTION COPY&#093;</B>
</DIV>

<DIV style="width: 100%; border-bottom: 3px double black; font-size: 1pt; margin-top: 6pt">&nbsp;</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">AGREEMENT AND PLAN OF MERGER
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">by and among
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.,
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">KERMIT MERGER CORP.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">and
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">LASERSCOPE
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">Dated as of June&nbsp;3, 2006
</DIV>

<DIV style="width: 100%; border-bottom: 3px double black; font-size: 1pt; margin-top: 6pt">&nbsp;</DIV>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="84%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 0px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>1.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">THE OFFER</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Offer</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company Action</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Directors</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Grant of Top-Up Stock Option</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>2.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">THE MERGER</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Merger</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Effective Time</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Effects of the Merger</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Closing of the Merger</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.5</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Articles of Incorporation</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.6</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Bylaws</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.7</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Board of Directors; Officers</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>3.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">EFFECT OF THE MERGER ON THE CAPITAL STOCK OF THE CONSTITUENT CORPORATIONS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Conversion of Company Capital Stock</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Effect on Capital Stock of Merger Sub</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Dissenting Shares</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Treatment of Options and Other Stock-Based Awards; Company Employee Stock</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Purchase Plan</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>4.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">EXCHANGE OF CERTIFICATES FOR MERGER CONSIDERATION</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Parent to Make Merger Consideration Available</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Exchange of Shares</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Adjustments to Prevent Dilution</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>5.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">REPRESENTATIONS AND WARRANTIES OF THE COMPANY</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Corporate Organization</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Capitalization</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Authority; No Violation</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consents and Approvals</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.5</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SEC Filings</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.6</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Financial Statements</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.7</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Broker&#146;s Fees</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.8</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Absence of Certain Changes or Events</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.9</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Legal Proceedings</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.10</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Taxes</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.11</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee Benefit Plans</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.12</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Compliance with Applicable Law</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.13</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certain Contracts</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.14</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Undisclosed Liabilities</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;

</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS</B><br>(continued)
</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="84%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 0px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.15</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Anti-Takeover Provisions</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.16</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company Information</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.17</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title to Property</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.18</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Insurance</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.19</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Environmental Liability</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.20</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Intellectual Property</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.21</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Labor Matters</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.22</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Interested Party Transactions</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.23</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">FDA and Regulatory Matters</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.24</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Government Inspections</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.25</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">No Other Representations or Warranties</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>6.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">32</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Corporate Organization</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">32</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Authority; No Violation</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">32</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consents and Approvals</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Broker&#146;s Fees</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.5</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Legal Proceedings</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.6</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Financial Capability</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.7</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Parent Information</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.8</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">No Business Activities by Merger Sub</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.9</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ownership of Company Common Stock; No Other Agreements</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.10</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Acknowledgement of Parent</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>7.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">COVENANTS RELATING TO CONDUCT OF BUSINESS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Conduct of Business Prior to the Effective Time</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company Forbearances</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">No Fundamental Parent Changes</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>8.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">ADDITIONAL AGREEMENTS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proxy Statement; Other Filings</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Access to Information</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Merger With Shareholder Meeting</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Merger Without Shareholder Meeting</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.5</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Further Actions</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.6</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employees; Employee Benefit Plans</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.7</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Indemnification; Directors&#146; and Officers&#146; Insurance</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.8</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">No Solicitation</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.9</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 16 Matters</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">47</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.10</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">InnovaQuartz Stock Purchase Agreement</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">47</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.11</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Notification of Certain Matters</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">47</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">-ii-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS</B><br>(continued)
</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="84%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 0px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>9.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">CONDITIONS PRECEDENT</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">47</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>10.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">TERMINATION AND AMENDMENT</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">48</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">10.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Termination</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">48</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">10.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Effect of Termination</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">49</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">10.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amendment</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">10.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Extension; Waiver</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>11.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">GENERAL PROVISIONS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">11.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Nonsurvival of Representations, Warranties and Agreements</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">11.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Expenses</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">51</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">11.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Notices</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">51</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">11.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Interpretation; Construction</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">51</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">11.5</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Counterparts; Facsimile</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">52</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">11.6</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Entire Agreement</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">52</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">11.7</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Governing Law; Venue</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">52</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">11.8</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Severability</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">11.9</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Publicity</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">11.10</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Assignment; Third Party Beneficiaries</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">-iii-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INDEX OF DEFINED TERMS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="94%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Acquisition Proposal</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">46</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Affiliate</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Agreement of Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">AMS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Bankruptcy and Equity Exceptions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Business Day</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">California Secretary</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Capitalization Date</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Certificate</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">CGCL</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Claim</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Closing Date</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">COBRA</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Code</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Commitments</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Benefit Plans</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Board</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Common Stock</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Contract</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Disclosure Schedule</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Domain Name</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Material Adverse Effect</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Option</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Owned IP</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Preferred Stock</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Product</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Recommendation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Recommendation Change</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">45</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Registered IP</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Representatives</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Required Vote</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company SEC Reports</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Shareholder Meeting</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Source Code</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Stock Plans</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Confidentiality Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Continuing Directors</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Continuing Employees</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Dissenting Shareholders</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Dissenting Shares</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Effective Time</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Environmental Laws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ERISA</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;

</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INDEX OF DEFINED TERMS<br>(Cont.)</B>
</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="94%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ESPP</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Exchange Act</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Exchange Fund</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">FDA</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Fully Diluted Shares</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">GAAP</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Governmental Entity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">HIPPA</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">HSR Act</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Indemnified Parties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">InnovaQuartz</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">47</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">InnovaQuartz Stock Purchase Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">47</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Intellectual Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Intellectual Property Rights</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Knowledge of the Company</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Knowledge of Parent</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Legal Proceeding</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Liens</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Material Trade Secrets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,&nbsp;7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Merger Consideration</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Merger Sub</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Minimum Condition</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">New Product Introductions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">32</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Offer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Offer Conditions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Offer Documents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Offer Price</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Option Consideration</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Option Exercise Minimum Condition</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Other Filings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent Material Adverse Effect</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">32</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent Plans</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Paying Agent</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Permitted Liens</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Person</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Proxy Statement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Related Party</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Revised Minimum Condition</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;14D-9</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SEC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Securities Act</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Shareholder Agreements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Shares</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">-v-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INDEX OF DEFINED TERMS<br>(Cont.)</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="94%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Subsidiary</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Superior Proposal</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">46</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Surviving Company</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Tax Return</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Taxes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Termination Date</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">48</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Termination Fee</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">49</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Top-Up Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Top-Up Exercise Notice</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Top-Up Notice Date</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Top-Up Option Shares</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Top-Up Stock Option</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Top-Up Termination Time</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">-vi-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>AGREEMENT AND PLAN OF MERGER</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This AGREEMENT AND PLAN OF MERGER, dated as of June&nbsp;3, 2006 (as amended, supplemented or
otherwise modified from time to time, and together with all schedules hereto, this &#147;<B><I>Agreement</I></B>&#148;), is
entered into by and among AMERICAN MEDICAL SYSTEMS HOLDINGS, INC., a Delaware corporation
(&#147;<B><I>Parent</I></B>&#148;), KERMIT MERGER CORP., a California corporation and an indirect subsidiary of Parent
(&#147;<B><I>Merger Sub</I></B>&#148;), and LASERSCOPE, a California corporation (the &#147;<B><I>Company</I></B>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>WHEREAS</I>, the respective Boards of Directors of each of the Company, Parent, and Merger Sub
have approved the acquisition of the Company by Parent on the terms and subject to the conditions
of this Agreement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Board of Directors of the Company has (a)&nbsp;determined that the Offer and the
Merger (both as defined herein) and the other transactions contemplated hereby are advisable and in
the best interests of the Company and its shareholders, (b)&nbsp;approved and adopted this Agreement and
the transactions contemplated hereby, including the Offer and the Merger, and (c)&nbsp;to the extent
required by applicable law, recommended that the Company&#146;s shareholders adopt this Agreement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>WHEREAS</I>, in furtherance thereof, it is proposed that Merger Sub shall, as promptly as
practicable, commence an offer (as it may be amended from time to time as permitted under this
Agreement, the &#147;<B><I>Offer</I></B>&#148;) to acquire all of the outstanding shares (the &#147;<B><I>Shares</I></B>&#148;) of Company Common
Stock (as defined in Section&nbsp;3.1(a)), at a price for each Share of $31.00 in cash (such price, or
such higher price per Share as may be paid in the Offer, is referred to as the &#147;<B><I>Offer Price</I></B>&#148;), in
accordance with the terms and subject to the conditions provided herein;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>WHEREAS</I>, also in furtherance thereof, it is proposed that, following the consummation of the
Offer, Merger Sub will merge with and into the Company (the &#147;<B><I>Merger</I></B>&#148;) and that the Shares not
tendered and accepted pursuant to the Offer will thereupon be converted into the right to receive
cash in the amounts set forth in Section&nbsp;3 hereof;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>WHEREAS</I>, simultaneously with the execution and delivery of this Agreement and as a condition
and inducement to the willingness of Parent and Merger Sub to enter into this Agreement, Parent and
the officers and directors of the Company are entering into agreements pursuant to which such
Persons will agree to tender for payment all of their Shares in the Offer, to the extent required
by applicable law, to vote to adopt and approve this Agreement and to take certain other actions in
furtherance of the transactions contemplated by this Agreement upon the terms and subject to the
conditions set forth in such agreements (the &#147;<B><I>Shareholder Agreements</I></B>&#148;); and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>WHEREAS</I>, the Company, Parent and Merger Sub desire to make certain representations,
warranties, covenants and agreements in connection with the Offer and the Merger and to prescribe
certain conditions to the Offer and the Merger.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>NOW, THEREFORE</I>, in consideration of the premises, and of the representations, warranties,
covenants and agreements contained herein, and intending to be legally bound hereby, the parties
hereto hereby agree as follows:
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>THE OFFER</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1 <U>The Offer</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Provided that (i)&nbsp;this Agreement shall not have been terminated in accordance with Section
10 and (ii)&nbsp;none of the events set forth in <U>Annex I</U> hereto shall have occurred or be
existing, Merger Sub shall, as promptly as practicable (and in any event not later than eight (8)
Business Days after the date of this Agreement), commence (within the meaning of Rule&nbsp;14d-2 under
the Exchange Act) the Offer for all of the Shares, at the Offer Price, without interest.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The obligation of Parent and Merger Sub to accept and pay for Shares tendered shall be
subject only to (i)&nbsp;the condition that there shall be validly tendered in accordance with the terms
of the Offer prior to the expiration date of the Offer and not withdrawn a number of Shares
(including the Shares tendered under the Shareholder Agreements) which, together with the Shares
then owned by Parent and Merger Sub, represents at least ninety percent (90%) of the total number
of Fully Diluted Shares (as defined below) (the &#147;<B><I>Minimum Condition</I></B>&#148;), subject to such waivers of,
and changes to, the Minimum Condition as may be required pursuant to Section&nbsp;1.1(e), and (ii)&nbsp;the
other conditions set forth in <U>Annex I</U> hereto (collectively, the &#147;<B><I>Offer Conditions</I></B>&#148;). For
purposes of this Agreement, &#147;<B><I>Fully Diluted Shares</I></B>&#148; shall mean the total number of outstanding
shares of Company Common Stock, assuming (A)&nbsp;exercise on a cash basis of all outstanding Company
Options, whether vested or unvested (excluding for this purpose all Company Options, whether vested
or unvested, held by holders who have entered into binding written agreements with the Company
agreeing to refrain from exercising all or any portion of such Company Options during any period
that the Offer remains pending <U>and</U> all Company Options with an exercise price greater than
the Offer Price, irrespective of whether the holders thereof have entered into such binding written
agreements), and (B)&nbsp;exercise or conversion of all other rights to acquire Company Common Stock or
securities convertible into Company Common Stock and issuance of all shares of Company Common Stock
that the Company is obligated to issue.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Parent and Merger Sub expressly reserve the right to waive any of the Offer Conditions and
to make any change in the terms or conditions of the Offer; <U>provided</U> that, without the
prior written consent of the Company, no change may be made which (i)&nbsp;changes the form or amount of
consideration to be paid (other than by adding consideration) or changes the number of Shares
sought in the Offer, (ii)&nbsp;imposes any conditions to the Offer other than the Offer Conditions or
modifies the Offer Conditions (other than to waive any Offer Condition to the extent permitted by
this Agreement), (iii)&nbsp;changes or waives the Minimum Condition, except as required pursuant to
Section&nbsp;1.1(e), (iv)&nbsp;extends the Offer beyond the initial expiration date of the Offer (except as
permitted or required by Section&nbsp;1.1(d)), or (v)&nbsp;makes any other change to the terms of the Offer
which is adverse to the holders of Shares.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Subject to the terms of the Offer and this Agreement, satisfaction of the Minimum
Condition (subject to such waivers of, and changes to, the Minimum Condition as may be required
pursuant to Section&nbsp;1.1(e)) and the absence (or waiver to the extent permitted by this Agreement)
of the other Offer Conditions, Merger Sub shall accept for payment all Shares validly tendered and
not withdrawn pursuant to the</DIV>

<P align="center" style="font-size: 10pt">-2-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Offer as soon as it is permitted to do so under applicable law and shall pay for all such Shares promptly after acceptance. The Offer shall
initially be scheduled to expire at 12:00 midnight Central time on the date that is the 20th
Business Day after the commencement date of the Offer. Notwithstanding anything to the contrary
contained in this Agreement, but subject to the parties&#146; termination rights under Section&nbsp;10.1, (i)
if, immediately prior to the initial expiration of the Offer, the number of Shares validly tendered
in accordance with the terms of the Offer and not withdrawn is at least seventy percent (70%) of
the Fully Diluted Shares but less than the Minimum Condition, Merger Sub shall have a one time
right to extend the expiration date of the Offer, without the consent of the Company, for an
additional period not to exceed ten (10)&nbsp;Business Days; (ii)&nbsp;if, immediately prior to the initial
expiration of the Offer, the number of Shares validly tendered in accordance with the terms of the
Offer is either (A)&nbsp;greater than thirty five percent (35%) of the Fully Diluted Shares but less
than forty nine and nine-tenths percent (49.9%) of the Fully Diluted Shares or (B)&nbsp;greater than
seventy percent (70%) of the Fully Diluted Shares but less than the Minimum Condition, the Company
shall have the right to require Merger Sub to extend the expiration date of the Offer for an
additional period not to exceed ten (10)&nbsp;Business Days; (iii)&nbsp;if, immediately prior to the initial
expiration of the Offer or the expiration of any extension thereof permitted or required pursuant
to this Section&nbsp;1.1(d), an unsolicited Acquisition Proposal has been made and remains pending,
Merger Sub shall have a one time right to extend, and the Company shall, so long as it has not
breached in any material respect its obligations under Section&nbsp;8.8, have a one time right to
require Merger Sub to extend, the expiration date of the Offer for an additional period not to
exceed ten (10)&nbsp;Business Days; (iv)&nbsp;if, immediately prior to the initial expiration date of the
Offer or any extension thereof permitted or required by this Section&nbsp;1.1(d), the Minimum Condition,
the Option Exercise Minimum Condition or the Revised Minimum Condition, as applicable, has been
satisfied but any of the other Offer Conditions exists and has not been waived, Merger Sub shall,
and Parent shall cause Merger Sub to, take all action necessary to extend the expiration date of
the Offer until the earlier of the removal or waiver of all of such other Offer Conditions or the
termination of this Agreement; and (v)&nbsp;without the consent of the Company, Merger Sub shall have
the right, subject to its compliance with the terms of this Agreement, to extend the expiration
date of the Offer for any period required by any rule, regulation, interpretation or position of
the Securities Exchange Commission (the &#147;<B><I>SEC</I></B><B>&#148;</B>) applicable to the Offer. Except as set forth in the
preceding sentence, the expiration date of the Offer shall not be extended without the prior
written consent of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Notwithstanding anything to the contrary set forth herein, if, at the end of the initial
expiration of the Offer or any extension thereof permitted or required pursuant to Section&nbsp;1.1(d),
the Minimum Condition is not satisfied but the number of Shares then tendered pursuant to the Offer
and not withdrawn is equal to or greater than forty nine and nine-tenths percent (49.9%) of the
Fully Diluted Shares, then, at the request of the Company and subject to any right of Parent or
Merger Sub to terminate this Agreement pursuant to the terms hereof, Merger Sub shall, and Parent
shall cause Merger Sub to: (i)&nbsp;exercise the Top-Up Stock Option (as defined below), waive the
Minimum Condition, and, in contemplation of the exercise of the Top-Up Stock Option, reduce the
number of shares of Company Common Stock subject to the Offer to that percentage of the Fully
Diluted Shares (the &#147;<B><I>Option Exercise Minimum Condition</I></B>&#148;) that, when combined with the number of
shares issued upon exercise of the Top-Up Stock Option, equals ninety percent (90%) of the Fully
Diluted Shares; or (ii)&nbsp;waive the Minimum Condition and amend the Offer to reduce the number of
shares of Company Common Stock subject to the Offer to 49.9% of the Fully Diluted
</DIV>

<P align="center" style="font-size: 10pt">-3-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Shares (the
&#147;<B><I>Revised Minimum Condition</I></B>&#148;) and, subject to the prior satisfaction or waiver of the other Offer Conditions,
purchase, on a pro rata basis, the number of Shares comprising the Revised Minimum Condition (it
being understood that the Company&#146;s right to require Merger Sub to take the actions described in
clause (ii)&nbsp;is triggered if and only if the exercise of the Top-Up Stock Option would not, when
combined with the number of Shares then tendered pursuant to the Offer and not withdrawn, result in
Merger Sub holding ninety percent (90%) of the Fully Diluted Shares; it being further understood
that Merger Sub shall not in any event be required to accept for payment, or pay for, any Shares if
the number of Shares tendered pursuant to the Offer and not withdrawn at the expiration date is
less than the Revised Minimum Condition).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;As soon as practicable on or prior to the date of commencement of the Offer, Parent and
Merger Sub shall (i)&nbsp;file with the SEC a Tender Offer Statement on Schedule&nbsp;TO with respect to the
Offer which will contain or incorporate by reference all or part of the form of the related letter
of transmittal (together with any supplements or amendments thereto, collectively the &#147;<B><I>Offer
Documents</I></B>&#148;) and (ii)&nbsp;cause the Offer Documents to be disseminated to holders of Shares. Parent,
Merger Sub and the Company each agree promptly to correct any information provided by it for use in
the Offer Documents if and to the extent that such information contains any untrue statement of a
material fact or omits to state any material fact required to be stated therein or necessary to
make the statements therein, in light of the circumstances under which they are made, not
misleading. Parent and Merger Sub agree to take all steps necessary to cause the Offer Documents
as so corrected to be filed with the SEC and to be disseminated to holders of Shares, in each case
as and to the extent required by applicable federal securities laws. The Company and its counsel
shall be given a reasonable opportunity to review and comment on the Schedule&nbsp;TO and the Offer
Documents before they are filed with the SEC.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2 <U>Company Action</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company hereby approves and consents to the Offer and represents that its Board of
Directors (the &#147;<B><I>Company Board</I></B>&#148;), at a meeting duly called and held, has unanimously (i)&nbsp;determined
that this Agreement and the transactions contemplated hereby, including the Offer and the Merger,
are advisable and are in the best interest of the Company&#146;s shareholders, (ii)&nbsp;approved this
Agreement and the transactions contemplated hereby, including the Offer and the Merger, and the
Shareholder Agreements and the transactions contemplated thereby, such that the Offer, the Merger,
this Agreement and the other transactions contemplated hereby and thereby are not and shall not be
subject to any state takeover statutes, and (iii)&nbsp;resolved to recommend acceptance of the Offer
and, to the extent required by applicable law, approval and adoption of this Agreement and the
Merger by the Company&#146;s shareholders (the recommendations referred to in this clause (iii)&nbsp;are
collectively referred to in this Agreement as the &#147;<B><I>Company Recommendation</I></B>&#148;). The Company further
represents that Goldman Sachs &#038; Co. has rendered to the Company Board its opinion that the $31.00
in cash to be received by the holders of Shares in the Offer and the Merger is fair from a
financial point of view to such holders. The Company has been advised that all of its directors
and executive officers presently intend to tender their Shares pursuant to the Offer pursuant to
the Shareholder Agreements. The Company will promptly furnish Parent and Merger Sub with a list of
its shareholders, mailing labels and any available listing or computer file containing the names
and addresses of all record holders of Shares and lists of securities positions of Shares held in
stock depositories, in each case as of the most
</DIV>

<P align="center" style="font-size: 10pt">-4-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">recent practicable date, engage a third party solicitor on customary terms
for the purpose of contacting all record holders of Shares regarding the Offer and provide to
Parent and Merger Sub such additional information (including, without limitation, updated lists of
shareholders, mailing labels and lists of securities positions) and such other assistance as Parent
or Merger Sub may reasonably request in connection with the Offer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As soon as practicable on the day that the Offer is commenced, the Company will file with
the SEC and disseminate to holders of Shares a Solicitation/Recommendation Statement on Schedule
14D-9 (the &#147;<B><I>Schedule&nbsp;14D-9</I></B>&#148;) which shall reflect the Company Recommendation. The Company, Parent
and Merger Sub each agree promptly to correct any information provided by it for use in the
Schedule&nbsp;14D-9 if and to the extent that it contains any untrue statement of a material fact or
omits to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they are made, not misleading. The Company
agrees to take all steps necessary to cause the Schedule&nbsp;14D-9 as so corrected to be filed with the
SEC and to be disseminated to holders of Shares, in each case as and to the extent required by
applicable federal securities laws. Parent and its counsel shall be given a reasonable opportunity
to review and comment on the Schedule&nbsp;14D-9 before it is filed with the SEC.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.3 <U>Directors</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Effective upon consummation of the Offer, Parent shall, subject to Section&nbsp;1.3(c), be
entitled to designate the number of directors, rounded up to the next whole number, on the Company
Board that equals the product of (i)&nbsp;the total number of directors on the Company Board (giving
effect to the election of any additional directors pursuant to this Section&nbsp;1.3) and (ii)&nbsp;the
percentage that the number of Shares owned by Parent or Merger Sub (including Shares accepted for
payment in connection with the Offer) bears to the total number of Shares then outstanding, and the
Company shall take all action necessary to cause Parent&#146;s designees to be elected or appointed to
the Company Board, including increasing the number of directors, or seeking and accepting
resignations of incumbent directors, or both; provided that, prior to the Effective Time, the
Company Board shall always have at least two (2)&nbsp;Continuing Directors (as defined below). If the
number of Continuing Directors is reduced to less than two (2)&nbsp;for any reason prior to the
Effective Time, the remaining and departing Continuing Directors shall be entitled to designate a
person to fill the vacancy. At such times, the Company will use its commercially reasonable
efforts to cause individuals designated by Parent to constitute the same percentage as such
individuals represent on the Company Board of (x)&nbsp;each committee of the Company Board, (y)&nbsp;each
board of directors of each subsidiary and (z)&nbsp;each committee of each such board. Notwithstanding
anything in this Agreement to the contrary, in the event that Parent&#146;s designees are elected to the
Company Board prior to the Effective Time, the unanimous affirmative vote of the Continuing
Directors shall be required for the Company to (a)&nbsp;amend or terminate this Agreement or agree or
consent to any amendment or termination of this Agreement, (b)&nbsp;waive any of the Company&#146;s rights,
benefits or remedies hereunder, (c)&nbsp;extend the time for performance of Parent&#146;s and Merger Sub&#146;s
respective obligations hereunder, or (d)&nbsp;approve any other action by the Company which is
reasonably likely to adversely affect the interests of the shareholders of the Company (other than
Parent, Merger Sub and their Affiliates (other than the Company and its Subsidiaries)), with
respect to the transactions contemplated by this Agreement. In addition, in the event approval of

</DIV>

<P align="center" style="font-size: 10pt">-5-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the
Company&#146;s shareholders is required by applicable law in order to consummate the Merger other than pursuant to Section&nbsp;1110 of the
CGCL, the Continuing Directors shall retain responsibility for, and control over, the Company&#146;s
obligations with respect to the Other Filings (as defined in Section&nbsp;8.1(a) hereof). For purposes
of this Agreement, &#147;<B><I>Continuing Directors</I></B>&#148; shall mean members of the Company Board who were
directors of the Company prior to the consummation of the Offer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company&#146;s obligations to appoint designees to the Company Board shall be subject to
Section 14(f) of the Exchange Act and Rule&nbsp;14f-l promulgated thereunder. The Company shall
promptly take all actions required pursuant to Section 14(f) and Rule&nbsp;14f-l in order to fulfill its
obligations under this Section&nbsp;1.3 and shall include in the Schedule&nbsp;14D-9 such information with
respect to the Company and its officers and directors as is required under Section 14(f) and Rule
14f-l to fulfill its obligations under this Section&nbsp;1.3. Parent will supply to the Company in
writing and be solely responsible for any information with respect to itself and its nominees,
officers, directors and Affiliates required by Section 14(f) and Rule&nbsp;14f-1. The provisions of
Section&nbsp;1.3(a) are in addition to and shall not limit any rights that Parent, Merger Sub or any of
their Affiliates may have as a holder or beneficial owner of Shares as a matter of law with respect
to the election of directors or otherwise.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Parent agrees that it will not exercise its right to designate members of the Company
Board pursuant to this Section&nbsp;1.3 in any manner that would result in the Company becoming
non-compliant with the corporate governance requirements of the Nasdaq National Market applicable
to listed companies, including Rule&nbsp;4350 thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.4 <U>Grant of Top-Up Stock Option</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Subject to the terms and conditions set forth herein, the Company hereby grants to Merger
Sub an irrevocable option (the &#147;<B><I>Top-Up Stock Option</I></B>&#148;) to purchase that number of newly-issued
shares of Company Common Stock (the &#147;<B><I>Top-Up Option Shares</I></B>&#148;) equal to the number of shares of
Company Common Stock that, when added to the number of shares of Company Common Stock owned by
Merger Sub, Parent and their Subsidiaries immediately following consummation of the Offer and the
issuance of such Top-Up Option Shares, shall constitute ninety percent (90%) of the total number of
Fully Diluted Shares (assuming the issuance of the Top-Up Option Shares), at a purchase price per
Top-Up Option Share equal to the Offer Price; <I>provided, however, </I>that (i)&nbsp;the total number of
shares of Company Common Stock subject to the Top-Up Stock Option shall not exceed the number of
authorized shares of Company Common Stock available for issuance by the Company at such time
(giving effect to such shares of Company Common Stock reserved for issuance pursuant to outstanding
Company Options or pursuant to the ESPP as though such shares of Company Common Stock were
outstanding), (ii)&nbsp;the number of Top-Up Shares subject to the Top-Up Option shall not exceed 19.9%
of the total number of shares of Company Common Stock outstanding immediately prior to such
issuance and (iii)&nbsp;the Company shall not be required to issue shares of Company Common Stock
pursuant to the Top-Up Stock Option if any temporary restraining order, preliminary or permanent
injunction or other order issued by any court of competent jurisdiction or other legal or
regulatory restraint then in effect shall prohibit such issuance. The Company agrees to provide
Parent and Merger Sub with information regarding the number of shares of Company Common Stock
available for issuance on an ongoing basis, as and when requested by Parent from time to time prior
to the Top-Up Termination Time (as defined below).
</DIV>

<P align="center" style="font-size: 10pt">-6-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Merger Sub shall, if and only if required by the Company pursuant to Section&nbsp;1.1(e) prior
to the Top-Up Termination Date, promptly exercise the Top-Up Stock Option in whole, but not in
part.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except as provided in the last sentence of this Section&nbsp;1.4(c), the &#147;<B><I>Top-Up Termination
Time</I></B>&#148; shall occur upon the earliest to occur of: (i)&nbsp;the Effective Time, and (iii)&nbsp;the termination
of this Agreement. The occurrence of the Top-Up Termination Time shall not affect any rights
hereunder which by their terms do not terminate or expire prior to or as of such date, unless this
Agreement has been terminated under Section&nbsp;10 prior to the occurrence of the Top-Up Closing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;In the event Merger Sub is obligated pursuant to this Agreement to exercise the Top-Up
Stock Option, Merger Sub shall send to the Company a written notice (a &#147;<B><I>Top-Up Exercise Notice</I></B>,&#148;
the date of which notice is referred to herein as the &#147;<B><I>Top-Up Notice Date</I></B>&#148;) specifying the
denominations of the certificate or certificates evidencing the Top-Up Option Shares which Merger
Sub wishes to receive, the place for the closing of the purchase and sale pursuant to the Top-Up
Stock Option (the &#147;<B><I>Top-Up Closing&#148;) </I></B>and a closing date not earlier than one (1)&nbsp;day nor later than
three (3)&nbsp;Business Days from the Top-Up Notice Date for the Top-Up Closing. The Company shall,
promptly after receipt of the Top-Up Exercise Notice, deliver a written notice to Parent and Merger
Sub confirming the number of Top-Up Option Shares and the aggregate purchase price therefor.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>THE MERGER</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1 <U>The Merger</U>. Upon the terms and subject to the conditions of this Agreement, in
accordance with the California General Corporation Law (&#147;<B><I>CGCL</I></B>&#148;), at the Effective Time (as
hereinafter defined), Merger Sub shall merge with and into the Company (the &#147;<B><I>Merger</I></B>&#148;). The Company
shall be the surviving corporation (hereinafter sometimes called the &#147;<B><I>Surviving Company</I></B>&#148;) of the
Merger, and shall continue its corporate existence under the laws of the State of California. Upon
consummation of the Merger, the separate corporate existence of Merger Sub shall terminate.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2 <U>Effective Time</U>. The Merger shall become effective as set forth in an agreement of
merger or certificate of ownership pursuant to Section&nbsp;1110 of the CGCL satisfying the applicable
requirements of the CGCL (in either case, the &#147;<B><I>Agreement of Merger</I></B>&#148;), together with such other
certificates satisfying the applicable requirements of the CGCL, which shall be duly executed by
the Company and Merger Sub and filed with the Secretary of State of the State of California (the
&#147;<B><I>California Secretary</I></B>&#148;) on the Closing Date (as hereinafter defined) or as soon thereafter as
practicable. As used herein, the term &#147;<B><I>Effective Time</I></B>&#148; shall mean the date and time when the Merger
becomes effective as provided by the Agreement of Merger and otherwise in accordance with
applicable law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.3 <U>Effects of the Merger</U>. At and after the Effective Time, the Merger shall have the
effects and consequences set forth in Section&nbsp;1107 of the CGCL.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.4 <U>Closing of the Merger</U>. Upon the terms and subject to the conditions of this
Agreement, the closing of the Merger (the &#147;<B><I>Closing</I></B>&#148;)
</DIV>

<P align="center" style="font-size: 10pt">-7-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"> will take
place (a)&nbsp;at the offices of Orrick, Herrington &#038; Sutcliffe LLP, 405 Howard Street, San Francisco, California, at 7:00 a.m.,
California time, on the date that is the second Business Day after the satisfaction or waiver of
the conditions set forth in Section&nbsp;9 hereof, other than conditions which by their terms are to be
satisfied at the Closing, or (b)&nbsp;such other location, date or time as the parties may mutually
agree (the &#147;<B><I>Closing Date</I></B>&#148;). For purposes of this Agreement, a &#147;<B><I>Business Day</I></B>&#148; shall mean any day
that is not a Saturday, a Sunday or other day on which the office of the California Secretary is
closed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.5 <U>Articles of Incorporation</U>. At the Effective Time, the Articles of Incorporation
of the Surviving Company shall be amended and restated in their entirety to be identical to the
Articles of Incorporation of Merger Sub, as in effect immediately prior to the Effective Time,
until thereafter amended in accordance with applicable law; <I>provided, however, </I>that at the
Effective Time, Article&nbsp;I of the Articles of Incorporation of the Surviving Company shall be
amended to read as follows: &#147;Laserscope&#148;.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.6 <U>Bylaws</U>. At the Effective Time, the Bylaws of the Surviving Company shall be
amended and restated in their entirety to be identical to the Bylaws of Merger Sub, as in effect
immediately prior to the Effective Time, until thereafter amended in accordance with applicable
law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.7 <U>Board of Directors; Officers</U>. The directors of Merger Sub immediately prior to
the Effective Time shall be the directors of the Surviving Company, each to hold office in
accordance with the Articles of Incorporation and Bylaws of the Surviving Company and applicable
law, until the earlier of their resignation or removal or until their respective successors are
duly elected or appointed (as the case may be) and qualified. The officers of Merger Sub
immediately prior to the Effective Time shall be the officers of the Surviving Company, each to
hold office in accordance with the Articles of Incorporation and Bylaws of the Surviving Company
and applicable law, until the earlier of their resignation or removal or until their respective
successors are duly elected or appointed (as the case may be).
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>EFFECT OF THE MERGER ON THE CAPITAL STOCK OF THE CONSTITUENT CORPORATIONS</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1 <U>Conversion of Company Capital Stock</U>. At the Effective Time, by virtue of the
Merger and without any action on the part of Parent, the Company or the holder of any of the shares
of Company Common Stock:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;All shares of common stock, without par value, of the Company (the &#147;<B><I>Company Common Stock</I></B>&#148;)
owned directly by the Company, Merger Sub or Parent (other than shares in trust accounts, managed
accounts and the like or shares held in satisfaction of a debt previously contracted) shall be
cancelled and retired and shall not represent capital stock of the Surviving Company and shall not
be exchanged for the Merger Consideration (as defined below); and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each outstanding share of Company Common Stock (other than those cancelled pursuant to
Section&nbsp;3.1(a) and Dissenting Shares (as defined below)) shall be converted into and become the
right to receive an amount in cash, without interest, equal to the Offer Price (the &#147;<B><I>Merger
Consideration</I></B>&#148;).
</DIV>

<P align="center" style="font-size: 10pt">-8-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2 <U>Effect on Capital Stock of Merger Sub</U>. At and after the Effective Time, each
share of common stock, without par value, of Merger Sub issued and outstanding immediately prior to
the Effective Time shall be converted into and become one (1)&nbsp;fully paid share of common stock,
without par value, of the Surviving Company and constitute the only outstanding shares of capital
stock of the Surviving Company and shall not be effected by the Merger.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3 <U>Dissenting Shares</U>. Notwithstanding anything in this Agreement to the contrary, in
the event that the applicable requirements of Section 1300(b) of the CGCL have been satisfied,
shares of Company Common Stock that are issued and outstanding immediately prior to the Effective
Time and that are held by a shareholder (the &#147;<B><I>Dissenting Shareholders</I></B>&#148;) who (a)&nbsp;voted such
shareholder&#146;s shares of Company Common Stock against the Merger (or did not consent thereto in
writing, if approval the Merger is obtained by written consent), (b)&nbsp;is entitled to demand and
properly demand that the Company purchase such shares at their fair market value in accordance with
Section&nbsp;1301 of the CGCL, (c)&nbsp;has submitted such shares for endorsement in accordance with Section
1302 of the CGCL and (d)&nbsp;has not otherwise failed to perfect or effectively withdrawn or lost such
right to require the Company to so purchase such shares, shall not be converted into or be
exchangeable for the right to receive the Merger Consideration (the &#147;<B><I>Dissenting Shares</I></B>&#148;), but
instead such Dissenting Shareholder shall be entitled to have the Dissenting Shares purchased by
the Company for cash at the fair market value thereof as agreed upon or determined in accordance
with the provisions of Chapter&nbsp;13 of the CGCL (and at the Effective Time, such Dissenting Shares
shall no longer be outstanding and shall automatically be canceled and shall cease to exist, and
such Dissenting Shareholder shall cease to have any rights with respect thereto, except the right
to have the Dissenting Shares purchased by the Company in accordance with the provisions of Chapter
13 of the CGCL), unless and until such Dissenting Shareholder shall have failed to perfect or shall
have effectively withdrawn or lost such right to require the Company to so purchase the Dissenting
Shares. If any Dissenting Shareholder shall have failed to perfect or shall have effectively
withdrawn or lost such right, such holder&#146;s shares of Company Common Stock shall thereupon be
treated as if they had been converted into and become exchangeable for the right to receive, as of
the Effective Time, the Merger Consideration for each such share of Company Common Stock, in
accordance with Section&nbsp;3.1(b), without any interest thereon. The Company shall give Parent (i)
prompt notice of any written demands for pursuant to Chapter&nbsp;13 of the CGCL, attempted withdrawals
of such demands and any other instruments served pursuant to Chapter&nbsp;13 of the CGCL and received by
the Company relating to a shareholder&#146;s demand that the Company purchase shares of Company Common
Stock, and (ii)&nbsp;the opportunity to direct all negotiations and proceedings with respect to such
demands. The Company shall not, except with the prior written consent of Parent, voluntarily make
any payment with respect to, or settle, or offer or agree to settle, any such demand for purchase
and payment.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4 <U>Treatment of Options and Other Stock-Based Awards; Company Employee Stock Purchase
Plan</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Except as provided below with respect to Company&#146;s 1999 Employee Stock Purchase Plan (the
&#147;<B><I>ESPP</I></B>&#148;), as of the Effective Time, each option to purchase shares of Company Common Stock or other
right to receive Company Common Stock under any Company Stock Plan (each a &#147;<B><I>Company Option</I></B>&#148;) which
is outstanding and unexercised immediately prior thereto shall become fully vested as of the
Effective Time
</DIV>

<P align="center" style="font-size: 10pt">-9-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and shall
by virtue of the Merger and without any action on the part of any holder of any Company Option be
cancelled and the holder thereof will receive as soon as reasonably practicable following the
Effective Time a cash payment (without interest) with respect thereto equal to the product of (i)
the excess, if any, of the Merger Consideration over the exercise price per share of such Company
Option and (ii)&nbsp;the number of shares of Company Common Stock issuable upon exercise of such Company
Option (collectively, the &#147;<B><I>Option Consideration</I></B>&#148;). The Option Consideration shall be reduced by
any withholding or other taxes that may be due as a result of the transactions contemplated by this
Section&nbsp;3.4. As of the Effective Time, all Company Options, whether or not vested or exercisable,
shall no longer be outstanding and shall automatically cease to exist, and each holder of a Company
Option shall cease to have any rights with respect thereto, except the right to receive the Option
Consideration, if any. The Company Board or compensation committee of the Company Board shall take
all necessary action to make such amendments and adjustments to or make such determinations with
respect to the Company Options as are necessary to implement the provisions of this Section&nbsp;3.4(a).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The &#147;offering period&#148; and &#147;purchase period&#148; (as defined in the ESPP) currently in process
as of the date of this Agreement under the ESPP shall continue and shares shall be issued to
participants thereunder as provided under, and subject to the terms and conditions of, the ESPP;
<I>provided, however</I>, that if the Effective Time occurs prior to the originally scheduled expiration
of such current purchase period, then immediately prior to the Effective Time, such current
purchase period under the ESPP shall be ended, and each participant shall be deemed to have
purchased immediately prior to the Effective Time, to the extent of payroll deductions accumulated
by such participant as of such purchase period end, the number of whole shares of Company Common
Stock at a per share price determined pursuant to the provisions of the ESPP, and each participant
shall receive a cash payment equal to the balance, if any, of such accumulated payroll deductions
remaining after such purchase of such shares. As of the Effective Time, all such deemed purchased
shares shall be converted into the right to receive cash pursuant to Section&nbsp;3.1. No offering
periods or purchase periods under the ESPP that are subsequent to the current purchase period in
process as of the date of this Agreement shall be commenced, and the ESPP and all purchase rights
thereunder shall terminate effective as of the Effective Time. The Company Board or compensation
committee of the Company Board shall take all necessary action to provide that participants under
the ESPP may not increase their payroll deductions from those in effect on the date of this
Agreement.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>EXCHANGE OF CERTIFICATES FOR MERGER CONSIDERATION</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1 <U>Parent to Make Merger Consideration Available</U>. Prior to the Effective Time,
Parent shall (a)&nbsp;deposit, or shall cause to be deposited, with a bank or trust company designated
by Parent and reasonably acceptable to the Company (the &#147;<B><I>Paying Agent</I></B>&#148;) in a separate fund (the
&#147;<B><I>Exchange Fund</I></B>&#148;), for the benefit of the holders of certificates or evidence of shares in
book-entry form which immediately prior to the Effective Time evidenced shares of Company Common
Stock (each a &#147;<B><I>Certificate</I></B>&#148;), an amount in cash sufficient to pay the aggregate Merger
Consideration and the Option Consideration, and (b)&nbsp;instruct the Paying Agent to timely pay the
Merger Consideration and the Option Consideration in accordance with this Agreement. The Merger
Consideration and the Option Consideration deposited with the Paying Agent pursuant to this Section
4.1 shall be invested by the Paying Agent as directed by Parent; <I>provided, however, </I>that any such
investment or any
</DIV>

<P align="center" style="font-size: 10pt">-10-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">payment of
earnings from any such investment shall not delay the receipt by the holders of record of the Certificates of the Merger Consideration or
otherwise impair such holders&#146; rights hereunder. Any interest or income produced by such
investments shall not be deemed part of the Exchange Fund and shall be payable to the Surviving
Company. In the event that the funds in the Exchange Fund shall be insufficient to make the
payments contemplated by Sections&nbsp;3.3 and 3.4, Parent shall promptly deposit, or cause to be
deposited, additional funds with the Paying Agent in an amount which is equal to the deficiency in
the amount required to make such payment. The Paying Agent shall cause the Exchange Fund to be (i)
held for the benefit of the holders of shares Company Common Stock and Company Options and (ii)
applied promptly to making the payments provided for in Section&nbsp;3. The Exchange Fund shall not be
used for any purpose that is not expressly provided for in this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2 <U>Exchange of Shares</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As soon as reasonably practicable after the Effective Time, the Paying Agent shall mail to
each holder of record of a Certificate a form of letter of transmittal (which shall specify that
delivery shall be effected, and risk of loss and title to the Certificates shall pass, only upon
delivery of the Certificates to the Paying Agent) and instructions for use in effecting the
surrender of the Certificates in exchange for payment of the Merger Consideration. Upon proper
surrender of a Certificate for exchange and cancellation to the Paying Agent, together with a
properly completed letter of transmittal, duly executed, the holder of such Certificate shall be
entitled to receive in exchange therefor a check representing the amount of the Merger
Consideration that such former holder has the right to receive pursuant to the provisions of
Section&nbsp;3, in each case, in respect of the Certificate surrendered pursuant to the provisions of
this Section&nbsp;4, and the Certificate so surrendered shall forthwith be cancelled.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If payment of the Merger Consideration is to be made to any Person other than the
registered holder of the Certificate surrendered in exchange therefor, it shall be a condition of
the payment thereof that the Certificate so surrendered shall be properly endorsed (or accompanied
by an appropriate instrument of transfer) and otherwise in proper form for transfer, and that the
Person requesting such exchange shall pay to the Paying Agent in advance any transfer or other
similar taxes required by reason of the payment of the Merger Consideration to any Person other
than the registered holder of the Certificate surrendered, or required for any other reason
relating to such holder or requesting Person, or shall establish to the reasonable satisfaction of
the Paying Agent that such tax has been paid or is not payable. As used herein, &#147;<B><I>Person</I></B>&#148; means an
individual, partnership, corporation, limited liability company, business trust, joint stock
company, trust, unincorporated association, joint venture or other entity of whatever nature.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;At or after the Effective Time, there shall be no transfers on the stock transfer books of
the Company of the shares of Company Common Stock which were issued and outstanding immediately
prior to the Effective Time. If, after the Effective Time, Certificates representing such shares
are presented for transfer to the Paying Agent, they shall be cancelled and exchanged for the
Merger Consideration as provided in this Section&nbsp;4.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Any portion of the Exchange Fund that remains unclaimed by the Company&#146;s shareholders for
one year after the Effective Time shall
</DIV>

<P align="center" style="font-size: 10pt">-11-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">be paid, at the request of Parent, to Parent. Any
shareholder of the Company who has not theretofore complied with this Section&nbsp;4 shall thereafter look only to Parent for payment of the Merger Consideration payable
in respect of each share of Company Common Stock held by such shareholder at the Effective Time as
determined pursuant to this Agreement, in each case, without any interest thereon. Notwithstanding
anything to the contrary contained herein, none of Parent, the Company, the Paying Agent, Merger
Sub or any other Person shall be liable to any former holder of shares of Company Common Stock for
any amount properly delivered to a public official pursuant to applicable abandoned property,
escheat or similar laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;In the event any Certificate shall have been lost, stolen or destroyed, upon the making of
an affidavit of that fact by the Person claiming such Certificate to be lost, stolen or destroyed
and, if required by Parent, the posting by such Person of a bond in such amount as Parent may
determine is reasonably necessary as indemnity against any claim that may be made against it with
respect to such Certificate, the Paying Agent will issue in exchange for such lost, stolen or
destroyed Certificate the Merger Consideration deliverable in respect thereof pursuant to this
Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Parent or the Paying Agent will be entitled to deduct and withhold from the consideration
otherwise payable pursuant to this Agreement or the transactions contemplated hereby to any holder
of Company Common Stock such amounts as Parent, or any affiliate (as defined under the Exchange Act
(an &#147;<B><I>Affiliate</I></B>&#148;)) thereof, or the Paying Agent are required to deduct and withhold with respect to
the making of such payment under the Internal Revenue Code of 1986, as amended (the &#147;<B><I>Code</I></B>&#148;), or any
applicable provision of U.S. federal, state, local or non-U.S. tax law. To the extent that such
amounts are properly withheld by Parent or the Paying Agent and paid over to the appropriate taxing
authority, such withheld amounts will be treated for all purposes of this Agreement as having been
paid to the holder of the Company Common Stock in respect of whom such deduction and withholding
were made by Parent or the Paying Agent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3 <U>Adjustments to Prevent Dilution</U>. Without limiting the other provisions of the
Agreement, in the event that the Company changes the number of shares of Company Common Stock
issued and outstanding prior to the Offer or the Effective Time as a result of a reclassification,
stock split (including a reverse stock split), stock dividend or distribution, recapitalization,
merger, subdivision, issuer tender or exchange offer, or other similar transaction, the Offer
Price, the Merger Consideration and the Option Consideration shall be equitably adjusted to reflect
such change.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">5.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in (a)&nbsp;the Company&#146;s filings with the SEC required by the Securities Act
(as defined below) or the Exchange Act (as defined below) during the two year period immediately
preceding the date of this Agreement, which filings shall qualify all sections and subsections of
this Agreement for which it is reasonably apparent from the face of the disclosure contained
therein that such disclosure is applicable or relevant, or (b)&nbsp;the disclosure schedule of the
Company delivered to Parent concurrently herewith (the &#147;<B><I>Company Disclosure Schedule</I></B>&#148;) (with
specific reference to the section of this Agreement to which the information stated in such Company
Disclosure Schedule relates; <I>provided </I>that (i)&nbsp;disclosure in any section of such Company Disclosure
Schedule shall be deemed to be disclosed with respect to any
</DIV>

<P align="center" style="font-size: 10pt">-12-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">other
Section of this Agreement to the extent that it is reasonably apparent from the face of such
disclosure that such disclosure is applicable or relevant to such other Section and (ii)&nbsp;the mere
inclusion of an item in such Company Disclosure Schedule as an exception to a representation or
warranty shall not be deemed an admission that such item represents a material exception or
material fact, event or circumstance or that such item has had or would have a Company Material
Adverse Effect), the Company hereby represents and warrants to Parent and Merger Sub as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1 <U>Corporate Organization</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company is a corporation duly organized, validly existing and in good standing under
the laws of the State of California. The Company has the corporate power and corporate authority to
own or lease all of its properties and assets and to carry on its business as it is now being
conducted, and is duly licensed or qualified to do business in each jurisdiction in which the
nature of the business currently conducted by it or the character or location of the properties and
assets owned or leased by it makes such licensing or qualification necessary, except where the
failure to be so licensed or qualified would not reasonably be expected to result in a Company
Material Adverse Effect. As used in this Agreement, the term &#147;<B><I>Company Material Adverse Effect</I></B>&#148;
means any change or effect that is (i)&nbsp;materially adverse to the business, operations, assets,
properties, results of operations or financial condition of the Company and its Subsidiaries taken
as a whole or (ii)&nbsp;prevents the Company from consummating the transactions contemplated hereby on a
timely basis; <I>provided, however, </I>that in determining whether a Company Material Adverse Effect has
occurred, there shall be excluded any effect on the Company or its Subsidiaries relating to or
arising in connection with (A)&nbsp;the negotiation (including activities relating to due diligence),
execution, delivery or public announcement or the pendency of this Agreement or the transactions
contemplated hereby or any actions required to be taken in compliance herewith (exclusive, however,
of the actions required to be taken by Section&nbsp;7.1 hereof) or otherwise with the consent of the
other party hereto, including the impact thereof on the relationships of the Company or any of its
Subsidiaries with customers, suppliers, distributors, consultants, employees or independent
contractors or other third parties with whom the Company or any of its Subsidiaries has any
relationship and including any litigation brought by any shareholder of the Company solely as a
result of the transactions contemplated hereby, (B)&nbsp;any event, occurrence, circumstance or trend,
including a diminution in value, related to the Company, any of its Subsidiaries or any of their
respective businesses, properties, assets, results of operations or financial condition that, to
the Knowledge of Parent, exists as of the date hereof, (C)&nbsp;any fact, circumstance or condition
disclosed in the Company Disclosure Schedule to the extent such change, effect or circumstance is
specifically set forth in the Company Disclosure Schedule or is reasonably apparent from the face
of the Company Disclosure Schedule without additional information, (D)&nbsp;any change in the market
price or trading volume of the Company&#146;s securities, in and of itself, (E)&nbsp;any failure, in and of
itself, by the Company to meet any projections or forecasts for any period ending (or for which
revenues or earnings are released) on or after the date hereof, (F)&nbsp;any change in federal, state,
non-U.S. or local law, regulations, policies or procedures, or interpretations thereof, generally
accepted accounting principles (&#147;<B><I>GAAP</I></B>&#148;) or regulatory accounting requirements applicable or
potentially applicable to the industries in which the Company or its Subsidiaries operate, (G)
changes generally affecting the industries in which the Company or its Subsidiaries operate, (H)
changes in economic conditions (including changes in the prevailing interest rates) in the United
States, in any region thereof, or in any non-U.S. or global economy or (I)&nbsp;any attack on,
</DIV>

<P align="center" style="font-size: 10pt">-13-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or by,
outbreak or escalation of hostilities or acts of terrorism involving, the United States, or any declaration of war by
the United States Congress or any hurricane or other natural disaster; <I>provided, however</I>, that the
changes referred to in clauses (F)&nbsp;through (I)&nbsp;do not have a materially disproportionate effect
(relative to other industry participants) on the Company and its Subsidiaries, taken as a whole.
As used herein, &#147;<B><I>Subsidiary</I></B>&#148; means, with respect to any Person, any corporation, partnership, joint
venture, limited liability company or any other entity that is consolidated with such Person for
financial reporting purposes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The copies of the Articles of Incorporation and Bylaws of the Company and the equivalent
organizational documents of each Subsidiary of the Company which have previously been made
available to Parent are true, complete and correct copies of such documents as in effect as of the
date of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Each Subsidiary of the Company (i)&nbsp;is duly organized and validly existing as a
corporation, partnership, limited liability company or other entity, as the case may be, under the
laws of its jurisdiction of organization, (ii)&nbsp;is duly licensed or qualified to do business and is
in good standing in all jurisdictions (whether federal, state, local or non-U.S.) where its
ownership or leasing of property or the conduct of its business requires it to be so licensed or
qualified and in which the failure to be so qualified would reasonably be expected to result in,
either individually or in the aggregate, a Company Material Adverse Effect and (iii)&nbsp;has all
requisite corporate or other requisite power and authority to own or lease its properties and
assets and to carry on its business as now conducted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The minute books of the Company and each of its Subsidiaries previously made available to
Parent contain true, complete and correct records in all material respects of all meetings and
other material corporate actions held or taken since January&nbsp;1, 2004 of their respective
shareholders, members, partners or other equity holders and Boards of Directors or other governing
bodies (including committees of their respective Boards of Directors or other governing bodies)
through the date hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.2 <U>Capitalization</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The authorized capital stock of the Company consists of 30,000,000 shares of Common Stock,
without par value, and 5,000,000 shares of Preferred Stock, without par value, (the &#147;<B><I>Company
Preferred Stock</I></B>&#148;). As of the close of business on June&nbsp;2, 2006 (the &#147;<B><I>Capitalization Date</I></B>&#148;), there
were 22,396,973 shares of Company Common Stock outstanding and no shares of Company Preferred Stock
outstanding. As of the close of business on the Capitalization Date, no shares of Company Common
Stock or Company Preferred Stock were reserved or to be made available for issuance, except as set
forth in Section&nbsp;5.2(a) of the Company Disclosure Schedule. All of the issued and outstanding
shares of Company Common Stock have been duly authorized and validly issued and are fully paid,
nonassessable and free of preemptive rights, with no personal liability attaching to the ownership
thereof. Except (i)&nbsp;as set forth in Section&nbsp;5.2(a) of the Company Disclosure Schedule, (ii)
pursuant to any cashless exercise provisions of any Company Options or pursuant to the surrender of
shares to the Company or the withholding of shares by the Company to cover tax withholding
obligations under the Company&#146;s stock plans and arrangements set forth in Section&nbsp;5.2(a) of the
Company Disclosure Schedule (collectively, and in each case as the same may be amended to
</DIV>

<P align="center" style="font-size: 10pt">-14-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"> the date hereof, the &#147;<B><I>Company Stock Plans</I></B>&#148;), and (iii)&nbsp;as set forth elsewhere in this Section&nbsp;5.2(a),
the Company does not have and is not bound by any outstanding subscriptions, options, warrants,
calls, commitments or agreements of any character calling for the purchase or issuance of any
shares of Company Common Stock or Company Preferred Stock or any other equity securities of the
Company or any securities representing the right to purchase or otherwise receive any shares of the
Company capital stock (including any rights plan or agreement). Section&nbsp;5.2(a) of the Company
Disclosure Schedule sets forth a true, complete and correct list of the aggregate number of shares
of Company Common Stock issuable upon the exercise of each stock option granted under the Company
Stock Plans that was outstanding as of the Capitalization Date and the exercise price for each such
stock option. Since the Capitalization Date, the Company has not (i)&nbsp;issued or repurchased any
shares of its capital stock or any securities convertible into or exercisable for any shares of its
capital stock, other than upon the exercise of employee stock options granted prior to such date
and disclosed in this Section&nbsp;5.2(a) or pursuant to the surrender of shares to the Company or the
withholding of shares by the Company to cover tax withholding obligations under the Company Stock
Plans, or (ii)&nbsp;issued or awarded any options, restricted shares or other equity-based awards under
the Company Stock Plans.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Section&nbsp;5.2(b) of the Company Disclosure Schedule lists the name, jurisdiction of
organization, authorized and outstanding shares of capital stock and record and beneficial owners
of such capital stock for each Subsidiary of the Company. Except as set forth in Section&nbsp;5.2(b) of
the Company Disclosure Schedule, neither the Company nor any of its Subsidiaries own, directly or
indirectly, any equity or similar interest in, or any interest convertible into or exchangeable
for, any equity or similar interest in, any corporation, partnership, joint venture or other
similar business association or entity (other than its wholly owned Subsidiaries). Except as set
forth in Section&nbsp;5.2(b) of the Company Disclosure Schedule, the Company owns, directly or
indirectly, all of the issued and outstanding shares of capital stock of or all other equity
interests in each of the Company&#146;s Subsidiaries free and clear of any liens, charges, encumbrances,
adverse rights or claims and security interests whatsoever (&#147;<B><I>Liens</I></B>&#148;), and all of such shares are
duly authorized and validly issued and are fully paid, nonassessable and free of preemptive rights,
with no personal liability attaching to the ownership thereof. Neither the Company nor any of its
Subsidiaries has or is bound by any outstanding subscriptions, options, warrants, calls,
commitments or agreements of any character calling for the purchase, sale or issuance of any shares
of capital stock or any other equity security of any Subsidiary of the Company or any securities
representing the right to purchase or otherwise receive any shares of capital stock or any other
equity security of any such Subsidiary.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.3 <U>Authority; No Violation</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company has full corporate power and corporate authority to execute and deliver this
Agreement and, subject to receipt of the Company Required Vote (as hereinafter defined) (to the
extent such Company Required Vote is required by applicable law), to consummate the transactions
contemplated hereby. The Company Board at a duly held meeting has (i)&nbsp;determined that this
Agreement, the Offer and the Merger are in the best interests of the Company and its shareholders
and declared this Agreement, the Offer and the Merger to be advisable, (ii)&nbsp;approved the Offer and
the Merger, the execution and delivery of this Agreement and the consummation of the transactions
contemplated hereby and (iii)&nbsp;subject to Section&nbsp;8.8, recommended that shareholders of the Company
adopt this Agreement and, if required by
</DIV>

<P align="center" style="font-size: 10pt">-15-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">applicable law, directed that such matter be submitted for consideration by the Company&#146;s
shareholders at the Company Shareholder Meeting (as hereinafter defined). Except for the adoption
of this Agreement by the affirmative vote of a majority of the outstanding shares of Company Common
Stock entitled to vote in accordance with applicable law, if required (the &#147;<B><I>Company Required
Vote</I></B>&#148;), no other corporate proceedings on the part of the Company are necessary to approve this
Agreement or to consummate the transactions contemplated hereby. This Agreement has been duly and
validly executed and delivered by the Company and (assuming due authorization, execution and
delivery by Parent and Merger Sub) constitutes a valid and binding obligation of the Company,
enforceable against the Company in accordance with its terms, except as enforcement may be limited
by general principles of equity whether applied in a court of law or a court of equity and by
bankruptcy, insolvency and similar laws affecting creditors&#146; rights and remedies generally (the
&#147;<B><I>Bankruptcy and Equity Exceptions</I></B>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Neither the execution and delivery of this Agreement by the Company nor the consummation
by the Company of the transactions contemplated hereby (including, without limitation, the Offer
and the Merger), nor compliance by the Company with any of the terms or provisions hereof, will (i)
violate any provision of the Articles of Incorporation or Bylaws of the Company or any of the
similar governing documents of any of its Subsidiaries or (ii)&nbsp;assuming that the consents,
approvals and filings referred to in Section&nbsp;5.4 are duly obtained or made, (A)&nbsp;violate any
statute, code, ordinance, rule, regulation, judgment, order, writ, decree or injunction applicable
to the Company or any of its Subsidiaries or any of their respective properties or assets, or (B)
violate, conflict with, result in a breach of any provision of, or require redemption or repurchase
or otherwise require the purchase or sale of any securities, constitute a default (or an event
which, with notice or lapse of time, or both, would constitute a default) under, result in the
termination of or a right of termination or cancellation under, accelerate the performance required
by, or result in the creation of any Lien upon any of the respective properties or assets of the
Company or any of its Subsidiaries under, any of the terms, conditions or provisions of any note,
bond, mortgage, indenture, deed of trust, license, lease, agreement or other instrument or
obligation to which the Company or any of its Subsidiaries is a party, or by which they or any of
their respective properties or assets may be bound or affected, except (in the case of clause (ii)
above) for such violations, conflicts, breaches, defaults or other events which, either
individually or in the aggregate, would not reasonably be expected to result in a Company Material
Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.4 <U>Consents and Approvals</U>. No consents or approvals of, or filings or registrations
with, any federal or state court, administrative agency or commission or other governmental
authority or instrumentality or self-regulatory organization of competent jurisdiction (each a
&#147;<B><I>Governmental Entity</I></B>&#148;) or with any third Person are necessary in connection with the execution and
delivery by the Company of this Agreement or the consummation by the Company of the Merger and the
other transactions contemplated hereby, except for (a)&nbsp;any notices required to be filed under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the &#147;<B><I>HSR Act</I></B>&#148;), (b)&nbsp;the filing
with the SEC of a proxy statement in definitive form relating to the Company Shareholder Meeting
(the &#147;<B><I>Proxy Statement</I></B>&#148;) as well as any other filings required to be made with the SEC pursuant to
the Securities Act or the Exchange Act, (c)&nbsp;the filing of the Agreement of Merger and related
certificates with the California Secretary pursuant to the CGCL, and (d)&nbsp;consents or approvals of,
or filings or registrations with, Governmental
</DIV>

<P align="center" style="font-size: 10pt">-16-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Entities
or third parties, the failure of which to be obtained or made would not be reasonably expected to result in,
individually or in the aggregate, a Company Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.5 <U>SEC Filings</U>. The Company has filed all forms, reports, statements, certifications
and other documents (including all exhibits, amendments and supplements thereto) required to be
filed by it with the SEC since January&nbsp;1, 2004 (collectively, the &#147;<B><I>Company SEC Reports</I></B>&#148;). None of
the Company&#146;s Subsidiaries is required to file periodic reports with the SEC pursuant to the
Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated
thereunder (the &#147;<B><I>Exchange Act</I></B>&#148;). Each of the Company SEC Reports, as amended prior to the date of
this Agreement, complied as to form in all material respects with the applicable requirements of
the Securities Act of 1933, as amended, and the rules and regulations of the SEC promulgated
thereunder (the &#147;<B><I>Securities Act</I></B>&#148;) and the Exchange Act, each as in effect on the date so filed (or
if amended or superseded by a filing prior to the date of this Agreement, then on the date of such
subsequent filing). None of the Company SEC Reports contained, when filed or, if amended or
supplemented prior to the date hereof, as of the date of such amendment or supplement, any untrue
statement of a material fact or omitted to state a material fact required to be stated or
incorporated by reference therein or necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading. The Company has furnished
to Parent a complete and correct copy of any amendments or modifications which have not yet been
filed with the SEC but which are required to be filed, to reports, agreements, documents or other
instruments which previously had been filed by the Company with the SEC pursuant to the Securities
Act or the Exchange Act or any material agreements potentially required to be filed that have not
been so filed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.6 <U>Financial Statements</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each of the financial statements included (or incorporated by reference) in the Company
SEC Reports (including the related notes, where applicable), after giving effect to any
restatements made by the Company prior to the date of this Agreement and which have been provided
to Parent, fairly present in all material respects (subject, in the case of the unaudited
statements, to normal recurring adjustments, none of which would be reasonably expected to result
in, individually or in the aggregate, a Company Material Adverse Effect) the results of the
consolidated operations and changes in shareholders&#146; equity and consolidated financial position of
the Company and its Subsidiaries for the respective fiscal periods or as of the respective dates
therein set forth. Each of such financial statements (including the related notes, where
applicable), after giving effect to any restatements made by the Company prior to the date of this
Agreement and which have been provided to Parent, complies in all material respects with applicable
accounting requirements and with the published rules and regulations of the SEC with respect
thereto and each of such financial statements (including the related notes, where applicable) has
been prepared in accordance with GAAP, as in effect on the date or for the period with respect to
which such principles are applied, in all material respects consistently applied during the periods
involved, except in each case as indicated in such statements or in the notes thereto or, in the
case of unaudited statements, as permitted by Form 10-Q. The books and records of the Company and
its Subsidiaries have been, and are being, maintained in all material respects in accordance with
GAAP and any other applicable legal and accounting requirements and reflect only actual
transactions.
</DIV>

<P align="center" style="font-size: 10pt">-17-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The records, systems, controls, data and information of the Company and its Subsidiaries
are recorded, stored, maintained and operated under means (including any electronic, mechanical or
photographic process, whether computerized or not) that are under the exclusive ownership and
direct control of the Company or its Subsidiaries or accountants (including all means of access
thereto and therefrom), except for any non-exclusive ownership and non-direct control that would
not reasonably be expected to have a material adverse effect on the system of internal accounting
controls described below in this Section&nbsp;5.6(b). The Company (i)&nbsp;has established and maintains
disclosure controls and procedures (as defined in Rule&nbsp;13a-15(e) of the Exchange Act) to ensure
that material information relating to the Company, including its consolidated Subsidiaries, is made
known to the chief executive officer and the chief financial officer of the Company by others
within those entities and (ii)&nbsp;has disclosed, based on its most recent evaluation prior to the date
hereof, to the Company&#146;s outside auditors and the audit committee of the Company Board (A)&nbsp;any
significant deficiencies and material weaknesses in the design or operation of internal controls
over financial reporting (as defined in Rule&nbsp;13a-15(f) of the Exchange Act) which are reasonably
likely to adversely affect the Company&#146;s ability to record, process, summarize and report financial
information and (B)&nbsp;any fraud, whether or not material, that involves management or other employees
who have a significant role in the Company&#146;s internal controls over financial reporting. These
disclosures were made in writing by management to the Company&#146;s auditors and audit committee and a
copy has previously been made available to Parent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.7 <U>Broker&#146;s Fees</U>. Except for the Company&#146;s engagement of Goldman Sachs &#038; Co.,
neither the Company nor any of its Subsidiaries has employed any broker or finder or incurred any
liability for any broker&#146;s fees, commissions or finder&#146;s fees in connection with any of the
transactions contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.8 <U>Absence of Certain Changes or Events</U>. Except as set forth in Section&nbsp;5.8 of the
Company Disclosure Schedule or the Company SEC Reports, since March&nbsp;31, 2006, the Company and its
Subsidiaries have carried on their respective businesses in all material respects in the ordinary
course of business and there has not been:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;any change, effect, event, occurrence, state of facts or development that individually or
in the aggregate, has had or could reasonably be expected to have a Company Material Adverse
Effect;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;any declaration, setting aside or payment of any dividend or other distribution with
respect to any shares of capital stock of the Company, or any repurchase, redemption or other
acquisition by the Company or any of its Subsidiaries (other than any wholly-owned Subsidiary) of
any outstanding shares of capital stock or other equity or debt securities of, or other ownership
interests in, the Company;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;any split, combination or reclassification of any of its capital stock;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;any amendment of any provision of the Articles of Incorporation, Bylaws or other
governing documents of, or of any material term of any outstanding security issued by, the Company
or any of its Subsidiaries (other than any wholly-owned Subsidiary);
</DIV>


<P align="center" style="font-size: 10pt">-18-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;any incurrence, assumption or guarantee by the Company or any of its Subsidiaries of
any indebtedness for borrowed money;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi)&nbsp;any change in any method of accounting or accounting practice by the Company or any of
its Subsidiaries, except for any such change required by reason of a change in GAAP and concurred
with by the Company&#146;s independent public accountants;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii)&nbsp;issuance of any equity or debt securities of the Company other than pursuant to the
Company Stock Plans or Company Options in the ordinary course of business and consistent with past
practice;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii)&nbsp;acquisition or disposition of assets material to the Company and its Subsidiaries,
except for sales of inventory in the ordinary course of business consistent with past practice, or
any acquisition or disposition of capital stock of any third party (other than acquisitions or
dispositions of non-controlling equity interests of third parties in the ordinary course of
business) or any merger or consolidation with any third party, by the Company or any of its
Subsidiaries;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix)&nbsp;any creation or assumption by the Company or any of its Subsidiaries of any Lien on any
asset other than in the ordinary course of business consistent with past practice;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x)&nbsp;any individual capital expenditure (or series of related capital expenditures) either
involving more than $500,000 or outside the ordinary course of business;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xi)&nbsp;any material damage, destruction or loss (whether or not covered by insurance) from fire
or other casualty to its tangible property;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xii)&nbsp;any material increase in the base salary of any officer or employee of the Company;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xiii)&nbsp;any adoption, amendment, modification, or termination of any bonus, profit-sharing,
incentive, severance or other similar plan for the benefit of any of its directors, officers or
employees;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xiv)&nbsp;entry by the Company into any joint venture, partnership or similar agreement with any
person other than any of its Subsidiaries; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xv)&nbsp;any authorization of, or commitment or agreement to take any of, the foregoing actions
except as otherwise permitted by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.9 <U>Legal Proceedings</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Except as set forth in Section&nbsp;5.9(a) of the Company Disclosure Schedule, neither the
Company nor any of its Subsidiaries is a party to any, and there are no pending or, to the
Knowledge of the Company (as defined below), threatened, material legal, administrative, arbitral
or other proceedings, claims, actions or governmental or regulatory investigations of any nature
involving the Company or any of its Subsidiaries.
</DIV>



<P align="center" style="font-size: 10pt">-19-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&#147;<B><I>Knowledge
of the Company</I></B>&#148; means the actual knowledge of the directors and executive officers of the Company listed in Section
5.9(a) of the Company Disclosure Schedule, in each case without such individual being obligated to
conduct any special inquiry or investigation into the affairs or records of the Company. The
directors and executive officers of the Company listed in Section&nbsp;5.9(a) of the Company Disclosure
Schedule shall not be deemed to have knowledge (actual, constructive or otherwise) of any fact,
event, condition or occurrence known or deemed to be known by any other person other than as
expressly set forth in the foregoing sentence.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As of the date of this Agreement, except as set forth in Section&nbsp;5.9(b) of the Company
Disclosure Schedule, neither the Company nor any of its Subsidiaries or any of their businesses or
properties are subject to or bound by any injunction, order, judgment, decree or regulatory
restriction of any Governmental Entity specifically imposed upon the Company, any of its
Subsidiaries or the assets of the Company or any of its Subsidiaries which would reasonably be
expected to result in, individually or in the aggregate, a Company Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.10 <U>Taxes</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Except as set forth in Section&nbsp;5.10(a) of the Company Disclosure Schedule: (i)&nbsp;each of the
Company and its Subsidiaries has (A)&nbsp;duly and timely filed (including pursuant to applicable
extensions granted without penalty) all material Tax Returns (as hereinafter defined) required to
be filed by it, and such Tax Returns are true, correct and complete in all material respects, and
(B)&nbsp;paid in full all Taxes (as hereinafter defined) required to have been paid by them on or before
the date that the payment of such Taxes were due; (ii)&nbsp;no material deficiencies for any Taxes have
been proposed, asserted or assessed in writing against the Company or any of its Subsidiaries which
deficiencies have not since been resolved; and (iii)&nbsp;there are no material Liens for Taxes upon the
assets of either the Company or its Subsidiaries except for statutory liens for current Taxes not
yet due or Liens for Taxes that are being contested in good faith by appropriate proceedings and
for which reserves adequate in accordance with GAAP have been provided.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as set forth in Section&nbsp;5.10(b) of the Company Disclosure Schedule, neither the
Company nor any of its Subsidiaries (i)&nbsp;is or has ever been a member of an &#147;affiliated group&#148;
(other than a group the common parent of which is the Company) filing a consolidated tax return (or
a group of corporations filing a consolidated, combined or unitary income Tax Return under
comparable provisions of state, local or foreign Tax law) for any taxable period; (ii)&nbsp;is a party
to or bound by any tax sharing agreement or tax indemnity agreement, arrangement or practice; (iii)
has entered into a &#147;listed transaction&#148; within the meaning of Treasury Regulation sections
1.6011-4(b)(2); or (iv)&nbsp;has any liability for Taxes of any Person (other than the Company and its
Subsidiaries) arising from the application of Treasury Regulation section 1.1502-6 or any analogous
provision of state, local or non-U.S. law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;No closing agreement pursuant to Section&nbsp;7121 of the Code (or any similar provision of
state, local or non-U.S. law) has been entered into by or with respect to the Company or any of its
Subsidiaries.
</DIV>


<P align="center" style="font-size: 10pt">-20-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;None of the Company or any of its Subsidiaries has been a &#147;distributing corporation&#148; or a
&#147;controlled corporation&#148; in any distribution occurring during the last five years in which the
parties to such distribution treated the distribution as one to which Section&nbsp;355 of the Code is
applicable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;All Taxes required to be withheld, collected or deposited by or with respect to the
Company and each Subsidiary have been timely withheld, collected or deposited as the case may be,
and to the extent required, have been paid to the relevant taxing authority, except for failures to
so withhold, collect or deposit that are immaterial, individually and in the aggregate, or for
which adequate reserves have been established in accordance with GAAP.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Neither the Company nor any of its Subsidiaries has granted any waiver of any federal,
state, local or non-U.S. statute of limitations with respect to, or granted any extension of a
period for the assessment of, any Tax, which waiver or extension has not since expired.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Neither the Company nor any of its Subsidiaries will be required to include in a taxable
period ending after the Effective Time taxable income attributable to income that accrued in a
prior taxable period (or portion of a taxable period) but was not recognized for tax purposes in
any prior taxable period as a result of (A)&nbsp;an open transaction disposition made on or before the
Effective Time, (B)&nbsp;a prepaid amount received on or prior to the Effective Time, (C)&nbsp;the
installment method of accounting, (D)&nbsp;the long-term contract method of accounting, (E)&nbsp;the cash
method of accounting or (F)&nbsp;any comparable provisions of state, local, domestic or foreign tax law,
other than any amounts that are reflected in a reserve for Taxes on the most recent financial
statements of the Company included in the Company SEC Reports;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;Neither the Company nor any of its Subsidiaries will be required to include any item of
income in, or exclude any item of deduction from, taxable income for any taxable period (or portion
thereof) ending after the Effective Time as a result of any: (A)&nbsp;change in method of accounting
for a taxable period ending on or prior to the Effective Time pursuant to Section&nbsp;481 of the Code,
or otherwise; (B) &#147;closing agreement&#148; as described in Section&nbsp;7121 of the Code (or any
corresponding or similar provision of state, local or foreign income Tax law) executed on or prior
to the Effective Time; or (C)&nbsp;intercompany transaction or excess loss account described in Treasury
Regulations under Section&nbsp;1502 of the Code (or any corresponding or similar provision of state,
local or foreign income Tax law), other than any amounts that are reflected in a reserve for Taxes
on the most recent financial statements of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;Neither the Company nor any of its Subsidiaries is a party to any agreement, contract,
arrangement or plan that has resulted or could result, separately or in the aggregate, in the
payment of (i)&nbsp;any &#147;excess parachute payment&#148; within the meaning of Section&nbsp;280G of the Code (or
any corresponding provision of state, local or foreign Tax law) and (ii)&nbsp;any amount that will not
be fully deductible as a result of Section 162(m) of the Code (or any corresponding provision of
state, local or foreign Tax law).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;As used herein, &#147;<B><I>Taxes</I></B>&#148; shall mean all taxes, charges, levies or other assessments imposed
by any United States federal, state, local or
</DIV>



<P align="center" style="font-size: 10pt">-21-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">non-U.S.
taxing authority, including income, excise, property, sales, transfer, franchise, payroll, withholding, social
security or other similar taxes, including any interest or penalties attributable thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;As used herein, &#147;<B><I>Tax Return</I></B>&#148; shall mean any return, report, information return or other
document (including any related or supporting information) required to be filed with any taxing
authority with respect to Taxes, including all information returns relating to Taxes of third
parties, any claims for refunds of Taxes and any amendments or supplements to any of the foregoing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.11 <U>Employee Benefit Plans</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Section&nbsp;5.11(a) of the Company Disclosure Schedule sets forth a true and complete list or
description of each employee benefit plan, arrangement, policy, program or agreement and any
amendments or modifications thereof (including all stock purchase, stock option, stock incentive,
severance, employment, change-in-control, health/welfare plans, fringe benefit, bonus, incentive,
deferred compensation, pension and other agreements, programs, policies and arrangements, whether
formal or informal, oral or written, whether or not subject to the Employee Retirement Income
Security Act of 1974, as amended (&#147;<B><I>ERISA</I></B>&#148;)) that is sponsored by, or maintained or contributed to
as of the date of this Agreement by the Company or any of its Subsidiaries and any related funding
agreements thereto (collectively, the &#147;<B><I>Company Benefit Plans</I></B>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as set forth in Section&nbsp;5.11(b) of the Company Disclosure Schedule, the Company has
previously provided or made available to Parent true and complete copies of each of the Company
Benefit Plans and each of the following (if applicable): (i)&nbsp;the most recent actuarial valuation
report for each Company Benefit Plan, (ii)&nbsp;the most recent determination or opinion letter from the
Internal Revenue Service for each Company Benefit Plan that is intended to constitute a qualified
plan under Section 401(a) of the Code, (iii)&nbsp;any summary plan description by the Company or its
Subsidiaries concerning the extent of the benefits provided under a Company Benefit Plan, and (iv)
the most recent Form&nbsp;5500, including the attached schedules, required to have been filed with the
Internal Revenue Service.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Neither the Company nor any Person treated as a single employer with the Company under
Section&nbsp;414(b), (c), (m)&nbsp;or (o)&nbsp;of the Code or Sections&nbsp;3(5) or 4001(b)(1) of ERISA maintains or
sponsors (or has ever maintained or sponsored) or makes or is required to make (or has ever made
contributions) to any Company Benefit Plan that (i)&nbsp;is a &#147;multiemployer plan&#148; as defined in
Sections&nbsp;3(37) of ERISA, (ii)&nbsp;is subject to the funding requirements of Section&nbsp;412 of the Code or
Title IV of ERISA, (iii)&nbsp;provides for post-retirement medical, life insurance or other welfare-type
benefits (other than as required by Part&nbsp;6 of Subtitle B of Title I of ERISA or Section&nbsp;4980B of
the Code or under a similar state law), or (iv)&nbsp;is or was a &#147;welfare benefit fund&#148; as defined under
Section 418(e) of the Code or an organization described in Sections&nbsp;501(c)(9) or 501(c)(20) of the
Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The Company Benefit Plans and their related trusts intended to qualify under Sections&nbsp;401
and 501(a) of the Code are subject to current favorable determination or opinion letters from the
IRS and, to the Knowledge of the Company, nothing has occurred that is reasonably
</DIV>



<P align="center" style="font-size: 10pt">-22-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">likely to result
in the revocation of such letter, except where the failure to so
comply would not reasonably be expected to result in, individually or in the aggregate, a Company
Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The Company Benefit Plans have been maintained and administered in all material respects
in accordance with their terms and applicable laws, including, but not limited to, the applicable
health care continuation and notice provisions of the Consolidated Omnibus Budget Reconciliation
Act of 1985, as amended (&#147;COBRA&#148;) and the applicable requirements of the Health Insurance
Portability and Accountability Act of 1956, amended (&#147;HIPAA&#148;), except where the failure to so
comply would not reasonably be expected to result in, individually or in the aggregate, a Company
Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;There are no suits, actions, disputes, claims (other than routine claims for benefits),
arbitrations, administrative or other proceedings pending or, to the Knowledge of the Company,
threatened with respect to any Company Benefit Plan or any related trust or other funding medium
thereunder or with respect to the Company as the sponsor or fiduciary thereof or with respect to
any other fiduciary thereof, which would reasonably be expected to have a Company Material Adverse
Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Neither the Company nor any Person treated as a single employee with the Company under
Section&nbsp;414(b), (c), (m), or (o)&nbsp;of the Code or Section&nbsp;3(5) or 4001(b)(1) of ERISA is or was a
party to a collective bargaining agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.12 <U>Compliance with Applicable Law</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Except as set forth in Section&nbsp;5.12(a) of the Company Disclosure Schedule, the Company and
each of its Subsidiaries holds all licenses, registrations, franchises, permits, orders and
authorizations necessary for the lawful conduct of their respective businesses under and pursuant
to, and have complied with and are not in violation in any material respect under, any applicable
law, statute, order, rule or regulation of any Governmental Entity relating to the Company or any
of its Subsidiaries, except where the failure to hold such license, franchise, permit or
authorization or such non-compliance or violation would not, individually or in the aggregate,
reasonably be expected to result in a Company Material Adverse Effect, and neither the Company nor
any of its Subsidiaries has received written notice of any violations of any of the above which,
individually or in the aggregate, would reasonably be expected to result in a Company Material
Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Since the enactment of the Sarbanes-Oxley Act, the Company has been and is in compliance
in all material respects with (i)&nbsp;the applicable provisions of the Sarbanes-Oxley Act and (ii)&nbsp;the
applicable listing standards of NASDAQ, including those related to corporate governance.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Company and each of its Subsidiaries has complied in all material respects with all
applicable laws relating to government health care fraud and abuse (including the federal
Anti-Kickback Law, 42 U.S.C. &#167;1320a-7b, and the False Claims Act, 31 U.S.C. &#167;3729 <I>et seq</I>. and any
regulations related thereto, as well as with any similar state statutes).
</DIV>


<P align="center" style="font-size: 10pt">-23-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.13 <U>Certain Contracts</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Except as filed as an exhibit to the Company SEC Reports filed prior to the date hereof or
except as set forth in Section&nbsp;5.13(a) of the Company Disclosure Schedule, neither the Company nor
any of its Subsidiaries is a party to or is bound by any contract, arrangement, commitment or
understanding (whether written or oral) (i)&nbsp;which is a material contract (as defined in Item
601(b)(10) of Regulation&nbsp;S-K of the SEC) to be performed after the date of this Agreement, (ii)
which restricts the rights of the Company or any of its Subsidiaries to compete in any line of
business in any geographic area or with any Person, or which requires exclusive referrals of
business or requires the Company or any of its Subsidiaries to offer specified products or services
to their customers on a priority or exclusive basis, (iii)&nbsp;with or to a labor union or guild
(including any collective bargaining agreement), (iv)&nbsp;which relates to the incurrence of
indebtedness, any guarantee or the borrowing or lending of money in the principal amount of
$1,000,000 or more, (v)&nbsp;which grants any Person a right of first refusal, right of first offer or
similar right with respect to any material properties, assets or businesses of the Company or its
Subsidiaries, (vi)&nbsp;which involves the purchase or sale of assets with a purchase price of $500,000
or more in any single case or $1,000,000 in all such cases, (vii)&nbsp;which the Company or any of its
Subsidiaries has granted to, or obtained from, a third party a license to any Intellectual
Property, (viii)&nbsp;pursuant to which any agent, sales representative, distributor or other third
party markets or sells any Company Product, (ix) (A)&nbsp;with the Company&#146;s executive officers, (B)
with the Company&#146;s other employees involving annual compensation exceeding $125,000, and (C)&nbsp;with
any agents or consultants involving annual compensation exceeding $200,000, (x)&nbsp;involves a dollar
amount in excess of $1,000,000 or extends for a period of 12&nbsp;months or more (other than any
contract or commitment that is terminable on ninety (90)&nbsp;or fewer days notice without penalty), or
(xi)&nbsp;any partnership or joint venture agreement. Each contract, arrangement, commitment or
understanding of the type described in this Section&nbsp;5.13(a), whether or not publicly disclosed in
the Company SEC Reports filed prior to the date hereof or set forth in Section&nbsp;5.13(a) of the
Company Disclosure Schedule, is referred to herein as a &#147;<B><I>Company Contract</I></B>&#148;, and neither the Company
nor any of its Subsidiaries has received written notice of any material violation of a Company
Contract by any of the other parties thereto. The Company has made available to Parent all Company
Contracts.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as set forth in Section&nbsp;5.13(b) of the Company Disclosure Schedule, (i)&nbsp;each
Company Contract is valid and binding on the Company and in full force and effect (other than due
to the ordinary expiration of the term thereof), and, to the Knowledge of the Company, is valid and
binding on the other parties thereto, in each case, as enforceability may be limited by the
Bankruptcy and Equity Exceptions, (ii)&nbsp;the Company and each of its Subsidiaries has performed all
obligations required to be performed by it to date under each Company Contract, and (iii)&nbsp;no event
or condition exists which constitutes or, after notice or lapse of time or both, would constitute a
default on the part of the Company or any of its Subsidiaries under any such Company Contract,
except, in each case, with respect to the foregoing clauses (i)&nbsp;through (iii)&nbsp;as would not
reasonably be expected to result in, either individually or in the aggregate, a Company Material
Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.14 <U>Undisclosed Liabilities</U>.
Except for (a)&nbsp;liabilities that are fully reflected or
reserved against on the consolidated balance sheet of the Company included in the Company&#146;s
Quarterly Report on Form 10-Q for the quarter ended March&nbsp;31, 2006, (b)&nbsp;liabilities incurred in
</DIV>

<P align="center" style="font-size: 10pt">-24-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the ordinary course of business consistent with past practice since March&nbsp;31, 2006, (c)
liabilities arising under the terms of (but not from any breach or default under) any agreement,
contract, commitment, license, permit, lease or other instrument or obligation that is either (x)
disclosed in the Company Disclosure Schedule or (y)&nbsp;not required to be so disclosed by the terms of
this Agreement (and including any of the foregoing types of instruments or obligations that are
entered into or obtained after the date of this Agreement, as long such action does not result in a
breach of this Agreement), (d)&nbsp;liabilities incurred pursuant to or in connection with this
Agreement or the transactions contemplated hereby or (e)&nbsp;liabilities that would not reasonably be
expected to result in, individually or in the aggregate, a Company Material Adverse Effect, neither
the Company nor any of its Subsidiaries has any liability of any nature whatsoever (whether
absolute, accrued or contingent or otherwise and whether due or to become due) that would be
required by GAAP to be reflected in the consolidated balance sheet of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.15 <U>Anti-Takeover Provisions</U>.
To the Knowledge of the Company, no state takeover
statute or similar statute or regulation applies or purports to apply to the Company with respect
to the Offer, the Agreement, the Shareholder Agreements, the Merger or any of the transactions
contemplated hereby and thereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.16 <U>Company Information</U>.
Neither the Schedule&nbsp;14D-9 or the Offer Documents will, at
the respective times any such documents or any amendments or supplements thereto are filed with the
SEC, are first published, sent or given to shareholders or become effective under the Securities
Act, contain any untrue statement of a material fact or omit to state any material fact required to
be stated therein or necessary to make the statements therein not misleading. The Proxy Statement
will not, at the time the Proxy Statement is first mailed to the Company&#146;s shareholders or, at the
time of the Company Shareholder Meeting, contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they are made, not misleading. The Schedule
14D-9 and the Proxy Statement (except for such portions thereof as relate only to Parent, Merger
Sub or any of their respective Subsidiaries) will comply as to form in all material respects with
the requirements of all applicable laws, including the Exchange Act and the rules and regulations
thereunder. No representation or warranty is made by the Company with respect to statements made
or incorporated by reference therein based on information supplied by Parent or Merger Sub for
inclusion or incorporation by reference therein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.17 <U>Title to Property</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Real Property</U>. Except as disclosed in Section&nbsp;5.17(a) of the Company Disclosure
Schedule, the Company and its Subsidiaries do not own any real property. All real property and
fixtures material to the business, operations or financial condition of the Company and its
Subsidiaries are in substantially good condition and repair except as would not reasonably be
expected to result in, individually or in the aggregate, a Company Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Personal Property</U>. The Company and its Subsidiaries have good, valid and
marketable title to all tangible personal property owned by them, free and clear of all Liens other
than Permitted Liens, except where the failure to have such title would not reasonably be expected
to result in, either individually or in the aggregate, a Company Material Adverse Effect.
</DIV>


<P align="center" style="font-size: 10pt">-25-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">With respect to personal property used in the business of the Company and its Subsidiaries
which is leased rather than owned, neither the Company nor any Subsidiary thereof is in default
under the terms of any such lease the loss of which would reasonably be expected to result in,
either individually or in the aggregate, a Company Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Leased Property</U>. All leases of real property and all other leases material to the
Company and its Subsidiaries under which the Company or a Subsidiary, as lessee, leases real or
personal property are valid and binding in accordance with their respective terms, there is not
under such lease any existing default by the Company or such Subsidiary or, to the Knowledge of the
Company, the lessors thereunder, or any event which with notice or lapse of time would constitute
such a default, and in the case of real estate leases the Company or such Subsidiary quietly enjoys
the premises provided for in such lease except, in each case, as would not reasonably be expected
to result in, individually or in the aggregate, a Company Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As used herein, &#147;<B><I>Permitted Liens</I></B>&#148; means (i)&nbsp;Liens publicly disclosed in the Company SEC
Reports filed prior to the date hereof, (ii)&nbsp;Liens disclosed in Section&nbsp;5.17 of the Company
Disclosure Schedule, (iii)&nbsp;Liens for current Taxes not yet due and payable and other standard
exceptions commonly found in title policies in the jurisdiction where the property is located, (iv)
such encumbrances and imperfections of title, if any, as do not materially detract from the value
of the properties and do not materially interfere with the present or proposed use of such
properties or otherwise materially impair such operations, (v)&nbsp;Liens imposed or promulgated by laws
with respect to real property and improvements, including zoning regulations, (vi)&nbsp;mechanics&#146;,
carriers&#146;, workmen&#146;s, repairmen&#146;s and similar Liens incurred in the ordinary course of business or
(vii)&nbsp;Liens that would not reasonably be expected to result in, individually or in the aggregate, a
Company Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.18 <U>Insurance</U>.
The Company and its Subsidiaries are insured with reputable insurers
against such risks and in such amounts as the management of the Company reasonably has determined
to be prudent in accordance with industry practice (taking into account the cost and availability
of such insurance) except as would not reasonably be expected to result in, individually or in the
aggregate, a Company Material Adverse Effect. The Company and its Subsidiaries are in compliance
with their insurance policies, including any State Self Insurance program, and are not in default
under any of the terms thereof, except for any such non-compliance or default that would not
reasonably be expected to result in a Company Material Adverse Effect. Each such policy is
outstanding and in full force and effect (other than due to the ordinary expiration of the term
thereof) and, except as set forth on Section&nbsp;5.18 of the Company Disclosure Schedule. All premiums
and other payments due under any such policy have been paid.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.19 <U>Environmental Liability</U>. Except as set forth in Section&nbsp;5.19 of the Company
Disclosure Schedule, neither the Company nor any of its Subsidiaries has received any written
notice of any legal, administrative, arbitral or other proceedings, claims, actions, causes of
action or private environmental investigations or remediation activities or governmental
investigations of any nature seeking to impose, or that would reasonably be expected to result in
the imposition, on the Company or any of its Subsidiaries of any liability or obligation arising
under
</DIV>

<P align="center" style="font-size: 10pt">-26-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">common law standards relating to protection of the environment or human health, or under any
local, state or federal environmental statute, regulation or ordinance, including the Comprehensive
Environmental Response, Compensation and Liability Act of 1980, as amended (collectively,
&#147;<B><I>Environmental Laws</I></B>&#148;), which liability or obligation would reasonably be expected to result in a
Company Material Adverse Effect. During or prior to the period of (a)&nbsp;its or any of its
Subsidiaries&#146; ownership or operation of any of their respective current properties, (b)&nbsp;its or any
of its Subsidiaries&#146; participation in the management of any property, or (c)&nbsp;its or any of its
Subsidiaries&#146; holding of a security interest or other interest in any property, there were no
releases or threatened releases of hazardous, toxic, radioactive or dangerous materials or other
materials regulated under Environmental Laws in, on, under or affecting any such property in
violation of any Environmental Laws. Neither the Company nor any of its Subsidiaries is subject to
any agreement, order, judgment, decree, letter or memorandum by or with any Governmental Entity or
third Person imposing any material liability or obligation pursuant to or under any Environmental
Law that would reasonably be expected to result in a Company Material Adverse Effect. The Company
and its Subsidiaries are in compliance in all material respects with all Environmental Laws,
including possessing all material permits required for its currently conducted operations under
applicable Environmental Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any other provision of this Agreement to the contrary (including Section
5.12), the representations and warranties of the Company in this Section&nbsp;5.19 constitute the sole
representations and warranties of the Company with respect to any matter (including any liability)
relating to Environmental Laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.20 <U>Intellectual Property</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Except as, individually or in the aggregate, would not reasonably be expected to result in
a Company Material Adverse Effect, Section&nbsp;5.20(a) of the Company Disclosure Schedule accurately
identifies:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;in Section&nbsp;5.20(a)(i) of the Company Disclosure Schedule: (A)&nbsp;each domain name (&#147;<B><I>Company
Domain Name</I></B>&#148;) or trademark registration or application for trademark registration patent or patent
application, or copyright registration or application for copyright registration (&#147;<B><I>Company
Registered IP</I></B>&#148;) that is owned by or registered or filed in the name of any of the Company and its
Subsidiaries; and (B)&nbsp;the domain registrar (as to Company Domain Names) and jurisdiction (as to
Company Registered IP) in which such Company Domain Name or Company Registered IP has been
registered or filed; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;in Section&nbsp;5.20(a)(ii) of the Company Disclosure Schedule, each contract material to the
operation of the business of the Company or its Subsidiaries as presently conducted pursuant to
which any Intellectual Property Rights or Intellectual Property is licensed by or to Company or its
Subsidiaries, where the license of such Intellectual Property Rights or Intellectual Property is a
material element of such contract (other than software license agreements for any third-party
software that is generally available to the public at a cost of less than $50,000 and other than
non-exclusive licenses granted by Company or its Subsidiaries in connection with the provision of
services in the ordinary course of business).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company has made available to Parent an accurate and complete copy of the standard
form of the following documents and
</DIV>



<P align="center" style="font-size: 10pt">-27-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"> contracts
currently used by Company or its Subsidiaries (and no other standard form used by Company or its Subsidiaries at any time since
January&nbsp;1, 2004, has differed materially from the standard forms made available to Parent): (i)
employee agreement or similar contract with employees of the Company or its Subsidiaries containing
any assignment or license of Intellectual Property or Intellectual Property Rights or any
confidentiality provision; and (ii)&nbsp;consulting or independent contractor agreement or similar
contract containing any assignment or license of Intellectual Property or Intellectual Property
Rights or any confidentiality provision. To the Knowledge of the Company, all personnel, including
employees, agents, consultants and contractors, who have contributed to or participated in the
conception or development, or both, of the Intellectual Property on behalf of the Company and all
officers and technical employees of the Company either (i)&nbsp;have been a party to &#147;work-for-hire&#148;
arrangements or agreements with the Company in accordance with applicable federal and state law
that has accorded the Company full, effective, sole, exclusive and original ownership of all
tangible and intangible property thereby arising, or (ii)&nbsp;have executed appropriate instruments of
assignment in favor of the Company as assignee that have conveyed to the Company effective, sole
and exclusive ownership of all tangible and intangible property arising thereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Company or its Subsidiaries own all right, title and interest to and in the Company
Owned IP (other than Intellectual Property Rights or Intellectual Property licensed by the Company,
as identified in Section&nbsp;5.20(a)(ii) of the Company Disclosure Schedule and other than
non-exclusive licenses granted by the Company or its Subsidiaries in connection with the provision
of services in the ordinary course of business, free and clear of any Liens that would reasonably
be expected to materially interfere with the use of such Company Owned IP in providing any
services). To the Knowledge of the Company, all patents included in the Company Owned IP are valid
and enforceable. To the Knowledge of the Company, none of the information withheld from Parent
during due diligence on the basis of attorney-client privilege or work product immunity is
materially adverse to the ownership, validity or enforceability of any Company Owned IP. To the
Knowledge of the Company, the Intellectual Property owned or licensed by the Company and its
Subsidiaries constitutes all of the Intellectual Property necessary to the conduct of the business
of the Company and its Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Each of the Company and its Subsidiaries has taken reasonable steps to maintain the
confidentiality of and otherwise protect and enforce its rights in Company Owned IP that is a
trade secret and that is material to the operation of the business of the Company and its
Subsidiaries as presently conducted (&#147;<B><I>Material Trade Secrets</I></B>&#148;) including: (i)&nbsp;obtaining an
appropriate non-disclosure agreement with respect to the disclosure of any Material Trade Secrets
of Company or its Subsidiaries to a third party; and (ii)&nbsp;imposing restrictions on unauthorized
copying, unauthorized sale, transfer or use in connection with providing a third party with access
to such Material Trade Secrets.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;To the Knowledge of the Company, except as set forth on Section&nbsp;5.20(e) of the Company
Disclosure Schedule, neither the execution, delivery or performance of this Agreement nor the
consummation of any of the transactions contemplated hereby will result in or give any other Person
the right or option to cause, create, impose or declare: (i)&nbsp;a loss of, or Lien on, any Company
Owned IP; or (ii)&nbsp;the grant, assignment or transfer to any other Person of any license or other
right or interest under, to or in any of the Company Owned IP.
</DIV>


<P align="center" style="font-size: 10pt">-28-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;To the Knowledge of the Company, except as set forth on Section&nbsp;5.20(f) of the Company
Disclosure Schedule, no Person is infringing, misappropriating or otherwise violating, any Company
Owned IP that is material to the operation of the business of the Company and its Subsidiaries as
presently conducted. Section&nbsp;5.20(f) of the Company Disclosure Schedule: (i)&nbsp;accurately identifies
(and the Company has provided to Parent an accurate and complete copy of) each letter or other
written or electronic communication or correspondence that has been sent or otherwise delivered by
or to the Company and its Subsidiaries or any Representative of any of the Company and its
Subsidiaries since January&nbsp;1, 2003 regarding any actual, alleged or suspected infringement or
misappropriation of any Company Owned IP; and (ii)&nbsp;provides a brief description of the current
status of the matter referred to in such letter, communication or correspondence; <I>provided,
however, </I>that the Company is not required to provide the information described in clauses &#147;(i)&#148; and
"(ii)&#148; of this sentence for correspondence or other communications that have been sent from time to
time by the Company or any of its Subsidiaries to third parties based upon any unauthorized linking
to any website of the Company or its Subsidiaries, which correspondence or other communication did
not result in any litigation, informal dispute resolution or other Legal Proceeding.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;To the Knowledge of the Company, except as set forth on Section&nbsp;5.20(g) of the Company
Disclosure Schedule, the operations of the Company and its Subsidiaries as presently conducted do
not infringe, misappropriate or otherwise violate any Intellectual Property Right of any other
Person.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;Except as set forth on Section&nbsp;5.20(h) of the Company Disclosure Schedule, no claim or
Legal Proceeding with respect to infringement, misappropriation or violation of any Intellectual
Property Right is or, since January&nbsp;1, 2004, has been pending or, to the Knowledge of the Company,
threatened against any Company or its Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;To the Knowledge of the Company, except as set forth on Section&nbsp;5.20(i) of the Company
Disclosure Schedule, since January&nbsp;1, 2004, none of the Company or its Subsidiaries has received
any written notice or other written communication relating to any actual, alleged or suspected
infringement, misappropriation or violation of any Intellectual Property Right of another Person by
any of the Company or its Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;To the Knowledge of the Company, no Company Source Code has been delivered, licensed or
made available to any escrow agent or other Person (other than employees of the Company and its
Subsidiaries). None of the Company or its Subsidiaries has any duty or obligation (whether present,
contingent or otherwise) to deliver, license or make available any Company Source Code to any
escrow agent or other Person. Section&nbsp;5.20(j) of the Company Disclosure Schedule identifies each
contract pursuant to which the Company or its Subsidiaries is or may become obligated (with or
without the passage of time, the occurrence of certain events or otherwise) to provide Company
Source Code to any Person.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As used herein &#147;<B><I>Company Owned IP</I></B>&#148; shall mean all Intellectual Property Rights and Intellectual
Property with respect to which any of the Company or its Subsidiaries has the entire ownership
interest.
</DIV>

<P align="center" style="font-size: 10pt">-29-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As used herein &#147;<B><I>Company Source Code</I></B>&#148; shall mean any source code, or any portion, aspect or
segment of any source code, relating to any Intellectual Property owned by or licensed to any of
the Company or its Subsidiaries or otherwise used by any of the Company or its Subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As used herein &#147;<B><I>Intellectual Property</I></B>&#148; shall mean algorithms, apparatus, databases, data
collections, diagrams, formulae, inventions (whether or not
patentable), know&#150;how, logos, marks
(including brand names, product names, logos, and slogans), methods, processes, proprietary
information, protocols, schematics, specifications, software, software code (in any form, including
source code and executable or object code), techniques, user interfaces, URLs, web sites, works of
authorship and other forms of technology (whether or not embodied in any tangible form and
including all tangible embodiments of the foregoing, such as instruction manuals, laboratory
notebooks, prototypes, samples, studies and summaries).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As used herein &#147;<B><I>Intellectual Property Rights</I></B>&#148; shall mean all rights of the following types,
which may exist or be created under the laws of any jurisdiction in the world: (a)&nbsp;rights
associated with works of authorship, including exclusive exploitation rights, copyrights and moral
rights; (b)&nbsp;trademark, trade name and domain name rights and similar rights; (c)&nbsp;trade secret
rights; (d)&nbsp;patent and industrial property rights; (e)&nbsp;other proprietary rights in Intellectual
Property; and (f)&nbsp;rights in or relating to registrations, renewals, extensions, combinations,
divisions and reissues of, and applications for, any of the rights referred to in clauses &#147;(a)&#148;
through &#147;(e)&#148; above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As used herein &#147;<B><I>Legal Proceeding</I></B>&#148; shall mean any action, suit, litigation, arbitration,
proceeding (including any civil, criminal, administrative, investigative or appellate proceeding),
hearing, inquiry, audit, examination or investigation commenced, brought, conducted or heard by or
before, or otherwise involving, any court or other Governmental Entity or any arbitrator or
arbitration panel.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.21 <U>Labor Matters</U>.
Neither the Company nor any of its Subsidiaries is a party to or
is bound by any collective bargaining agreement, contract or other agreement or understanding with
a labor union or labor organization, nor is the Company or any of its Subsidiaries the subject of a
proceeding asserting that it or any such Subsidiary has committed an unfair labor practice (within
the meaning of the National Labor Relations Act) or seeking to compel the Company or any such
Subsidiary to bargain with any labor organization as to wages or conditions of employment, nor is
there any strike or other material labor dispute involving it or any of its Subsidiaries pending
or, to the Knowledge of the Company, threatened, nor, to the Knowledge of the Company, is there any
activity involving its or any of its Subsidiaries&#146; employees seeking to certify a collective
bargaining unit or engaging in other organizational activity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.22 <U>Interested Party Transactions</U>.
Since January&nbsp;1, 2004, except as publicly
disclosed in the Company SEC Reports or Section&nbsp;5.22 of the Company Disclosure Schedule: (a)&nbsp;no
event has occurred that would be required to be reported by the Company pursuant to Item&nbsp;404 of
Regulation&nbsp;S-K promulgated by the SEC; and (b)&nbsp;there are no existing contracts, agreements,
business dealings, arrangements or other understandings between the Company or any of its
Subsidiaries and any Related Party. There are no assets of any Related Party that are used in
</DIV>

<P align="center" style="font-size: 10pt">-30-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"> or necessary to the conduct of the business of the Company or any of its Subsidiaries. For
purposes of this Agreement, &#147;<B><I>Related Party</I></B>&#148; shall mean any officer, director or beneficial owner of
more than five percent (5%) of the outstanding voting securities of the Company or any of its
Subsidiaries (or any entity of which such person is an officer, director or beneficial owner of
more than five percent (5%) of such entity&#146;s outstanding voting securities).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.23 <U>FDA and Regulatory Matters</U>.
To the extent any product produced, manufactured,
marketed or distributed at any time by the Company or any of its Subsidiaries (&#147;<B><I>Company Product</I></B>&#148;)
is being marketed in the United States or internationally, the Company has obtained all necessary
approvals of the U.S. Food and Drug Administration (the &#147;<B><I>FDA</I></B>&#148;) and any other Governmental Entity
and is in compliance in all material respects with applicable laws relating to the manufacturing,
labeling, marketing and selling of medical devices. There have been no recalls, field
notifications or seizures ordered or adverse regulatory actions taken or, to the Company&#146;s
Knowledge, threatened by the FDA or any other Governmental Entity with respect to any of the
Company Products, including any facilities where any Company Products are produced, processed,
packaged or stored. All filings with and submissions to the FDA and any other Governmental Entity
made by the Company with regard to the Company Products were true, accurate and complete in all
material respects as of the date made, and, to the extent required to be updated, as so updated
remain true, accurate and complete in all material respects as of the date hereof, and do not
materially misstate any of the statements or information included therein, or omit to state a
material fact necessary to make the statements therein not misleading.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.24 <U>Government Inspections</U>.
The Company (i)&nbsp;is not a party to a Corporate Integrity
Agreement with the Office of the Inspector General of the Department of Health and Human Services,
(ii)&nbsp;has no reporting obligations pursuant to any settlement agreement entered into with any
governmental body, (iii)&nbsp;to the Company&#146;s Knowledge, has not been the subject of any Government
Program investigation conducted by any governmental body, (iv)&nbsp;has not been a defendant in any <I>qui
tam</I>/False Claims Act litigation (other than by reason of an unsealed complaint of which the Company
has no Knowledge), and (v)&nbsp;has not been served with or received any search warrant, subpoena, civil
investigation demand, contact letter, or to the Company&#146;s Knowledge, telephone or personal contact
by or from any Governmental Entity relating to any of the matters referred to in clauses (i)
through (v)&nbsp;above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.25 <U>No Other Representations or Warranties</U>.
Except for the representations and
warranties expressly contained in this Section&nbsp;5, neither the Company nor any other Person makes
any other express or implied representation or warranty with respect to the Company, the Company&#146;s
Subsidiaries or the transactions contemplated by this Agreement, and the Company disclaims any
other representations or warranties, whether made by the Company or any of its Affiliates,
officers, directors, employees, agents or representatives. Except for the representations and
warranties expressly contained in this Section&nbsp;5, the Company hereby disclaims all liability and
responsibility for any representation, warranty, projection, forecast, statement, or information
made, communicated, or furnished (orally or in writing) to Parent, Merger Sub or any of their
Affiliates or representatives (including any opinion, information, projection, or advice that may
have been or may be provided to Parent by any director, officer, employee, agent, consultant, or
representative of the Company or any of its Affiliates). Without limiting the generality of the

</DIV>

<P align="center" style="font-size: 10pt">-31-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">foregoing,
and for the avoidance of doubt, neither the Company nor any other Person makes any representation or warranty with respect to the performance of the
Company&#146;s new GreenLight HPS&#153; technology or any of the Company&#146;s other new urology products that
were introduced at the American Urological Association annual meeting in late May&nbsp;2006
(collectively, the &#147;<B><I>New Product Introductions</I></B>&#148;), the attractiveness of the New Product
Introductions to, or the rate of adoption of the New Product Introductions by, current and new
customers, the effect of the New Product Introductions on sales of the Company&#146;s other product
offerings, the Company&#146;s ability to ramp up production of the New Product Introductions to meet
anticipated demand, the Company&#146;s ability to compete with similar product offerings and other
therapies for the treatment of BPH, or the impact on sales and pricing of the New Product
Introductions and the Company&#146;s other product offerings of possible reductions in private and
public payer reimbursement levels for the PVP procedure.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">6. REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parent and Merger Sub hereby represent and warrant to the Company as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.1 <U>Corporate Organization</U>.
Each of Parent and Merger Sub is a corporation duly
organized, validly existing and in good standing under the laws of the state of its incorporation.
Each of Parent and Merger Sub has the corporate power and authority to own or lease all of its
properties and assets and to carry on its business as it is now being conducted, and is duly
licensed or qualified to do business in each jurisdiction in which the nature of the business
currently conducted by it or the character or location of the properties and assets owned or leased
by it makes such licensing or qualification necessary, except where the failure to be so licensed
or qualified would not reasonably be expected to result in a Parent Material Adverse Effect. The
copies of the charter documents of Parent and Merger Sub which have previously been made available
to the Company are true, complete and correct copies of such documents as in effect as of the date
of this Agreement. As used in this Agreement, a &#147;<B><I>Parent Material Adverse Effect</I></B>&#148; means a material
adverse effect on the ability of Parent or Merger Sub to consummate the transactions contemplated
by this Agreement in a timely manner or otherwise prevent or materially delay Parent or Merger Sub
from performing any of its material obligations under this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.2 <U>Authority; No Violation</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each of Parent and Merger Sub has full corporate power and authority to execute and
deliver this Agreement and to consummate the transactions contemplated hereby. The execution and
delivery of this Agreement and the consummation of the transactions contemplated hereby (including
the Offer and the Merger) have been duly and validly approved by the Board of Directors of Parent
and Merger Sub and no other corporate proceedings on the part of Parent or Merger Sub are necessary
to approve this Agreement or to consummate the transactions contemplated hereby. This Agreement has
been duly and validly executed and delivered by each of Parent and Merger Sub and (assuming due
authorization, execution and delivery by the Company) constitutes a valid and binding obligation of
Parent and Merger Sub, enforceable against each of Parent and Merger Sub in accordance with its
terms, except as enforcement may be limited by the Bankruptcy and Equity Exceptions.
</DIV>


<P align="center" style="font-size: 10pt">-32-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Neither the execution and delivery of this Agreement by Parent or Merger Sub, nor the
consummation by Parent or Merger Sub of the transactions contemplated hereby (including the Offer
and the Merger), nor compliance by Parent or Merger Sub with any of the terms or provisions hereof,
will (i)&nbsp;violate any provision of charter documents of Parent or Merger Sub or (ii)&nbsp;assuming that
the consents, approvals and filings referred to in Section&nbsp;6.3 are duly obtained or made, (A)
violate any statute, code, ordinance, rule, regulation, judgment, order, writ, decree or injunction
applicable to Parent, Merger Sub or any of their respective Subsidiaries or any of their respective
properties or assets, or (B)&nbsp;violate, conflict with, result in a breach of any provision of or the
loss of any benefit under, or require redemption or repurchase or otherwise require the purchase or
sale of any securities, constitute a default (or an event which, with notice or lapse of time or
both, would constitute a default) under, result in the termination of or a right of termination or
cancellation under, accelerate the performance required by, or result in the creation of any Lien
upon any of the respective properties or assets of Parent, Merger Sub or any of their respective
Subsidiaries under, any of the terms, conditions or provisions of any note, bond, mortgage,
indenture, deed of trust, license, lease, agreement or other instrument or obligation to which
Parent, Merger Sub or any of their respective Subsidiaries is a party, or by which they or any of
their respective properties or assets may be bound or affected, except (in the case of clause (ii)
above) for such violations, conflicts, breaches, defaults or other events which either individually
or in the aggregate would not reasonably be expected to result in a Parent Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.3 <U>Consents and Approvals</U>.
No consents or approvals of, or filings or registrations
with, any Governmental Entity or any third Person are necessary in connection with (a)&nbsp;the
execution and delivery by Parent or Merger Sub of this Agreement or (b)&nbsp;the consummation by Parent
or Merger Sub of the Offer or the Merger and the other transactions contemplated hereby, except for
(i)&nbsp;any notices required to be filed under the HSR Act, (ii)&nbsp;the filing of the Articles of Merger
and related certificates with the California Secretary pursuant to the CGCL, (iii)&nbsp;any notices or
filing requirements under the Exchange Act and (iv)&nbsp;consents or approvals of, or filings or
registrations with, Governmental Entities or third parties the failure of which to be obtained
would not be reasonably expected to result in, individually or in the aggregate, a Parent Material
Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.4 <U>Broker&#146;s Fees</U>.
Except as set forth in Schedule&nbsp;6.4, neither Parent, Merger Sub
nor any of their respective Subsidiaries has employed any broker or finder or incurred any
liability for any broker&#146;s fees, commissions or finder&#146;s fees in connection with any of the
transactions contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.5 <U>Legal Proceedings</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Neither Parent, Merger Sub nor any of their respective Subsidiaries is a party to any, and
there are no pending or, to the Knowledge of Parent, threatened, material legal, administrative,
arbitral or other material proceedings, claims, actions or governmental or regulatory
investigations of any nature challenging the validity or propriety of the transactions contemplated
by this Agreement. As used herein, &#147;<B><I>to the Knowledge of Parent</I></B>&#148; means the actual knowledge of the
officers of the Parent listed in Schedule&nbsp;6.5(a), in each case without such individual being
obligated to conduct any special inquiry or investigation into the affairs or records of the
Company. The officers of the Parent listed in
</DIV>



<P align="center" style="font-size: 10pt">-33-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;6.5(a)
shall not be deemed to have knowledge (actual, constructive or otherwise) of any fact, event, condition or
occurrence known or deemed to be known by any other person other than as expressly set forth in the
foregoing sentence.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;There is no injunction, order, judgment, decree or regulatory restriction of any
Governmental Entity specifically imposed upon Parent, Merger Sub or any of their respective
Subsidiaries or the assets of Parent, Merger Sub or any of their respective Subsidiaries which has
resulted in or would reasonably be expected to result in, individually or in the aggregate, a
Parent Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.6 <U>Financial Capability</U>. Parent, through its wholly owned subsidiary American
Medical Systems, Inc. (&#147;<B><I>AMS</I></B>&#148;), will have available at the consummation of the Offer sufficient
immediately available funds through cash on hand or binding credit facility commitments from
reputable lenders and financial institutions for borrowings of up to $745,000,000 in funds (the
&#147;<B><I>Commitments</I></B>&#148;), true and complete copies of which have been furnished to the Company, to enable
Merger Sub to perform all of its obligations under this Agreement, to consummate the Offer and the
Merger and to pay in full all fees and expenses payable by Parent in connection with this Agreement
and the transactions contemplated hereby. Each of the Commitments, in the form so delivered, is a
legal, valid and binding obligation of AMS and, to the Knowledge of Parent or Merger Sub, the other
parties thereto. No event has occurred which, with or without notice, lapse of time or both, would
constitute a default or breach on the part of AMS, Parent or Merger Sub under any term or condition
of the Commitments. Neither Parent nor Merger Sub has any reason to believe that AMS, Parent and
Merger Sub will be unable to satisfy on a timely basis any term or condition of closing to be
satisfied by it contained in the Commitments. AMS, Parent or Merger Sub will pay in full any and
all commitment fees or other fees required by the Commitments prior to the end of the first
Business Day following the date of this Agreement. Without limiting the generality of the
foregoing, Parent&#146;s ability to consummate the transactions contemplated hereby is not contingent on
Parent&#146;s ability to complete any public offering or private placement of equity or debt securities
or to obtain any other type of financing prior to consummating the Offer and the Merger<B>.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.7 <U>Parent Information</U>. Neither the Offer Documents nor any of the information
supplied or to be supplied by Parent or its Subsidiaries or representatives for inclusion or
incorporation by reference in the Schedule&nbsp;14D-9 or the Proxy Statement will, at the respective
times any such documents or any amendments or supplements thereto are filed with the SEC, are first
published, sent or given to shareholders or become effective under the Securities Act or, in the
case of the Proxy Statement, at the time of the Company Shareholder Meeting, contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or
necessary to make the statements therein not misleading. The Offer Documents will comply as to
form in all material respects with the requirements of all applicable laws, including the
Securities Act and the Exchange Act, as applicable, and the rules and regulations thereunder. No
representation or warranty is made by Parent or Merger Sub with respect to statements made or
incorporated by reference therein based on information supplied by the Company for inclusion or
incorporation by reference therein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.8 <U>No Business Activities by Merger Sub</U>. All of the outstanding capital stock of
Merger Sub is owned by AMS and all of the outstanding
</DIV>

<P align="center" style="font-size: 10pt">-34-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">capital
stock of AMS is owned by Parent. Merger Sub is not a party to any contract and has not conducted any activities other
than in connection with the organization of Merger Sub, the negotiation and execution of this
Agreement and the consummation of the transactions contemplated hereby. Merger Sub has no
Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.9 <U>Ownership of Company Common Stock; No Other Agreements</U>. Neither Parent, Merger
Sub nor any of their respective Subsidiaries or, to the Knowledge of Parent, any of their
respective Affiliates or associates (as such term is defined under the Exchange Act) (a)
beneficially owns, directly or indirectly, or (b)&nbsp;is a party to any agreement, arrangement or
understanding for the purpose of acquiring, holding, voting or disposing of, in case of either
clause (a)&nbsp;or (b), any Company Common Stock, in each case, except in accordance with this
Agreement, including the Offer and the Merger. Neither Parent, Merger Sub nor any of their
respective Subsidiaries or, to the Knowledge of Parent, any of their respective Affiliates or
associates (as such term is defined under the Exchange Act) has entered into any contract or
agreement with any officer or director of the Company in connection with the transactions
contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.10 <U>Acknowledgement of Parent</U>. Parent acknowledges and agrees that it has conducted
its own independent review and analysis of the business, assets, condition and operations of the
Company and its Subsidiaries. In entering into this Agreement, Parent has relied solely upon its
own investigation and analysis and the representations and warranties, covenants and agreements of
the Company contained in this Agreement and Parent (a)&nbsp;acknowledges that, other than as set forth
in this Agreement, none of the Company nor any of its respective directors, officers, employees,
Affiliates, agents or representatives makes or has made any representation or warranty, either
express or implied, as to the accuracy or completeness of any of the information provided or made
available to Parent or its agents or representatives prior to the execution of this Agreement, (b)
agrees, to the fullest extent permitted by law, that none of the Company nor any of its respective
directors, officers, employees, Affiliates, agents or representatives shall have any liability or
responsibility whatsoever to Parent on any basis (including in contract, tort or otherwise) based
upon any information provided or made available, or statements made, to Parent prior to the
execution of this Agreement, and (c)&nbsp;acknowledges that to the Knowledge of Parent, none of the
representations or warranties of the Company set forth in Section&nbsp;5 of this Agreement are untrue or
inaccurate.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">7. COVENANTS RELATING TO CONDUCT OF BUSINESS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.1 <U>Conduct of Business Prior to the Effective Time</U>. Except as expressly contemplated
or permitted by this Agreement, or as required by applicable law, rule or regulation, during the
period from the date of this Agreement to the Effective Time, the Company shall, and shall cause
each of its Subsidiaries to, conduct its business in the ordinary course.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.2 <U>Company Forbearances</U>. Without limiting the generality of Section&nbsp;7.1, except as
set forth in Section&nbsp;7.2 of the Company Disclosure Schedule, as expressly contemplated or permitted
by this Agreement, or as required by applicable law, rule or regulation, or by any
</DIV>

<P align="center" style="font-size: 10pt">-35-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"> Governmental
Entity, during the period from the date of this Agreement to the
Effective Time, the Company shall
not, and shall not permit any of its Subsidiaries to, without the prior written
consent of Parent (which consent shall not be unreasonably withheld or delayed); <I>provided,
however, </I>that consent of Parent shall be deemed to have been given if Parent does not object within
five (5)&nbsp;Business Days from the date on which request for such consent is provided by the Company
to Parent:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) (i)&nbsp;adjust, split, combine or reclassify its capital stock, (ii)&nbsp;set any record or payment
dates for the payment of any dividends or distributions on its capital stock or make, declare or
pay any dividend or make any other distribution on any shares of its capital stock or any
securities or obligations convertible into or exchangeable for any shares of its capital stock,
except that a wholly owned Subsidiary of the Company may declare and pay dividends to its parent
and other wholly owned Subsidiaries of the Company, (iii)&nbsp;directly or indirectly redeem, purchase
or otherwise acquire, any shares of its capital stock or any securities or obligations convertible
into or exchangeable for any shares of its capital stock (except pursuant to the exercise of stock
options outstanding as of the date hereof or permitted to be issued under this Section&nbsp;7.2 or
pursuant to the surrender of shares to the Company or the withholding of shares by the Company to
cover tax withholding obligations under the Company Stock Plans), or (iv)&nbsp;grant any stock
appreciation rights or grant any Person any right to acquire any shares of its capital stock, or
issue or commit to issue any additional shares of capital stock (except pursuant to the exercise of
stock options outstanding as of the date hereof or permitted to be issued under this Section&nbsp;7.2)
any securities convertible into or exercisable for, or any rights, warrants or options to acquire,
any additional shares of capital stock;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;sell, transfer, mortgage, encumber or otherwise dispose of any of its assets or properties
to any Person (other than a direct wholly owned Subsidiary), by merger, consolidation, asset sale
or other business combination (including formation of a joint venture) or cancel, release or assign
any indebtedness to any such Person or any claims held by any such Person, in each case, except (i)
in the ordinary course of business consistent with past practice, including sales of repossessed
assets, (ii)&nbsp;dispositions of obsolete or worthless assets, (iii)&nbsp;sales of loans, receivables and
other assets in the ordinary course of business consistent with past practice and (iv)&nbsp;sales of
immaterial assets which involve the sale of assets with a purchase price of $500,000 or less in any
single case or $1,000,000 in all such cases;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;make any acquisition, by purchase or other acquisition of stock or other equity interests,
by merger, consolidation, asset purchase or other business combination, or by contributions to
capital; or make any material purchases of any property or assets, in or from any other Person
other than a wholly owned Subsidiary of the Company, except (i)&nbsp;as expressly required by the terms
of any contracts or agreements in force at the date of this Agreement and set out in Section&nbsp;7.2(c)
of the Company Disclosure Schedule, (ii)&nbsp;as otherwise permitted by this Section&nbsp;7.2, and (iii)
other acquisitions in the ordinary course of business consistent with past practice and, in any
case, involving consideration in an aggregate amount not in excess of $500,000;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;enter into, renew, extend, amend or terminate any contract, lease or agreement that is or
would be a Company Contract;
</DIV>


<P align="center" style="font-size: 10pt">-36-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;other than general salary increases, including in connection with promotions, made in the
ordinary course of business consistent with past practice, for employees,
directors or independent contractors generally or as required by any agreement in effect on
the date hereof (true and correct copies of which have been delivered to Parent prior to the date
of this Agreement), (i)&nbsp;increase, or commit to increase, in any material respect the compensation
or severance payable to any of its employees, directors or independent contractors, (ii)&nbsp;pay any
severance, annual incentive payment or benefit in the form of a welfare benefit or discretionary
pension or retirement allowance contribution to any employees, directors or independent contractors
not required by any existing plan or agreement identified in Section&nbsp;5.11(a) of the Company
Disclosure Schedule or any agreement in effect on the date hereof (true and correct copies of which
have been delivered to Parent prior to the date of this Agreement), in any case in this clause (ii)
above other than in the ordinary course of business consistent with past practice (including in
terms of the amount of such payments on a per person basis, levels of benefits provided, timing of
payments, and selection of and eligibility requirements for the applicable recipients), which does
not otherwise materially increase the aggregate cost to the Company of paying all such payments and
benefits during the period in which this Section&nbsp;7.2(e) applies, from the aggregate cost to the
Company of paying all such payments and benefits during the same period of time in the immediately
preceding calendar year, or (iii)&nbsp;except as may be required, or advisable, to comply with
applicable law, amend, establish or enter into any pension, retirement, profit-sharing, severance,
retention or welfare benefit plan or agreement or incentive or employment, agreement with or for
the benefit of any employee, director or independent contractor or accelerate the vesting of any
stock options or other stock-based compensation;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;amend its Articles of Incorporation, Bylaws or similar governing documents;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;introduce any material new products or services or any material new sales compensation or
incentive programs or arrangements (except those the material terms of which have been fully
disclosed in writing to Parent prior to the date hereof);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;enter into any new material line of business or change its lending, investment, risk and
asset-liability management and other material operating policies in any material respect;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;incur any indebtedness for borrowed money, issue any debt securities or assume, guarantee
or endorse or otherwise become responsible for the obligations of another Person, except in the
ordinary course of business consistent with past practice;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;make or change any material Tax election or settle or compromise any material Tax
liability of the Company or any of its Subsidiaries;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;make any material changes in its accounting methods or method of Tax accounting, practices
or policies, except as may be required under applicable law, rule, regulation or GAAP;
</DIV>


<P align="center" style="font-size: 10pt">-37-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;except as permitted pursuant to Section&nbsp;8.8, take any action that is intended or may
reasonably be expected to result in any of the conditions to the Merger set forth in Section&nbsp;9 not
being satisfied;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)&nbsp;institute, settle or compromise any claim, action, suit or proceeding pending or
threatened by or against it, at law or in equity or before any Governmental Entity or any
non-governmental self-regulatory agency; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n)&nbsp;agree to, or make any commitment to, take any of the actions prohibited by this Section
7.2.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.3 <U>No Fundamental Parent Changes</U>. Except as expressly contemplated or permitted by
this Agreement or as required by applicable law, rule or regulation, during the period from the
date of this Agreement to the Effective Time, neither Parent nor Merger Sub shall, without the
prior written consent of the Company (which consent shall not be unreasonably withheld), (a)&nbsp;take
any action that is intended or may reasonably be expected to result in any of the Offer Conditions
set forth in <U>Annex I</U> or any of the conditions to the Merger set forth in Section&nbsp;9 not
being satisfied, (b)&nbsp;take any action or fail to take any action which would reasonably be expected
to materially and adversely impair or delay consummation of the transactions contemplated hereby
beyond the time period contemplated by this Agreement or (c)&nbsp;agree to, or make any commitment to,
take any of the actions prohibited by this Section&nbsp;7.3.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">8. ADDITIONAL AGREEMENTS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.1 <U>Proxy Statement; Other Filings</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;If approval of the Company&#146;s shareholders is required by applicable law in order to
consummate the Merger other than pursuant to Section&nbsp;1110 of the CGCL, within ten (10)&nbsp;Business
Days of a request to do so by Parent, (a)&nbsp;the Company (under the direction of the Continuing
Directors) shall prepare and file with the SEC the preliminary Proxy Statement, and (b)&nbsp;each of the
Company (under the direction of the Continuing Directors) and Parent shall, or shall cause their
respective Affiliates to, prepare and file with the SEC any other filings that are required to be
filed by such party with the SEC (&#147;<B><I>Other Filings</I></B>&#148;) in connection with the transactions contemplated
hereby. Each of the Company and Parent shall furnish all information concerning itself and its
Affiliates that is required to be included in the Proxy Statement or, to the extent applicable, the
Other Filings, or that is customarily included in proxy statements or other filings prepared in
connection with transactions of the type contemplated by this Agreement. Each of the Company and
Parent shall use its commercially reasonable efforts to respond as promptly as practicable to any
comments of the SEC with respect to the Proxy Statement or the Other Filings, and the Company shall
use its commercially reasonable efforts to cause the definitive Proxy Statement to be mailed to the
Company&#146;s shareholders as promptly as reasonably practicable after the filing of such definitive
Proxy Statement with the SEC. Each party shall promptly notify the other parties upon the receipt
of any comments from the SEC or its staff or any request from the SEC or its staff for amendments
or supplements to the Proxy Statement or the Other Filings and shall provide the other party with
copies of all correspondence between it and its Representatives, on the one hand, and the SEC and
its staff, on the other hand relating to the Proxy Statement or the Other Filings. If at any time
prior to the
</DIV>




<P align="center" style="font-size: 10pt">-38-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Company Shareholder Meeting, any information relating to the Company, Merger Sub,
Parent or any of their respective Affiliates, officers or directors, should be discovered by the
Company or Parent which should be set forth in an amendment or supplement to the Proxy Statement or
the Other Filings, so that the Proxy Statement or the Other Filings shall not contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein
or necessary in order to make the statements therein, in light of the circumstances under which
they are made, not misleading, the party which discovers such information shall promptly notify the
other parties, and an appropriate amendment or supplement describing such information shall be
filed with the SEC and, to the extent required by applicable law, disseminated to the shareholders
of the Company. Notwithstanding anything to the contrary stated above, prior to filing or mailing
the Proxy Statement or filing the Other Filings (or, in each case, any amendment or supplement
thereto) or responding to any comments of the SEC with respect thereto, the party responsible for
filing or mailing such document shall provide the other party a reasonable opportunity to review
and comment on such document or response.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Subject to the other provisions of this Agreement, the parties hereto shall cooperate with
each other and use commercially reasonable efforts to promptly prepare and file all necessary
documentation, to effect all applications, notices, petitions and filings, to obtain as promptly as
practicable all material permits, consents, approvals and authorizations of all third parties and
Governmental Entities which are necessary or advisable to consummate the transactions contemplated
by this Agreement (including the Offer and the Merger) and to comply with the terms and conditions
of all such permits, consents, approvals and authorizations of all such third parties and
Governmental Entities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Parent and the Company shall, upon request, furnish each other with all information
concerning themselves, their Subsidiaries, directors, officers and shareholders and such other
matters as may be reasonably necessary or advisable in connection with any statement, filing,
notice or application made by or on behalf of Parent, the Company or any of their respective
Subsidiaries to any Governmental Entity in connection with the Offer and the Merger and the other
transactions contemplated by this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Nothing in this Section&nbsp;8.1 shall be deemed to prevent the Company or the Company Board
from taking any action they are permitted or required to take under, and in compliance with,
Section&nbsp;8.8 or are required to take under applicable law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.2 <U>Access to Information</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Upon reasonable prior notice and subject to applicable law, the Company shall, and shall
cause each of its Subsidiaries to, afford to the officers, employees, accountants, counsel and
other representatives of Parent access, during normal business hours during the period prior to the
Effective Time, to all its properties, books, contracts, commitments and records, and to its
officers, employees, accountants, counsel and other representatives, in each case in a manner not
unreasonably disruptive to the operation of the business of the Company and its Subsidiaries, and,
during such period, the Company shall, and shall cause its Subsidiaries to, make available to
Parent (i)&nbsp;a copy of each report, schedule, registration statement and other document filed or
received by it during such period pursuant to the requirements of federal securities
</DIV>



<P align="center" style="font-size: 10pt">-39-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">laws or
federal or state lending laws (other than reports or documents which
the Company is not permitted
to disclose under applicable law) and (ii)&nbsp;all other information concerning its business,
properties and personnel as Parent may reasonably request. At the request of Parent, the Company
shall comply with its obligations under the preceding sentence by providing electronic access to
such documents and information on the online data room
established by the Company prior to the date hereof. Neither the Company nor any of its
Subsidiaries shall be required to provide access to or to disclose information where such access or
disclosure would (A)&nbsp;jeopardize the attorney-client privilege of the institution in possession or
control of such information, (B)&nbsp;contravene any law, rule, regulation, order, judgment, decree,
fiduciary duty or binding agreement entered into prior to the date of this Agreement in the
ordinary course of business consistent with past practice, or (C)&nbsp;be adverse to the interests of
the Company or any of its Subsidiaries in any pending or threatened litigation between the parties
hereto over the terms of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;All information and materials furnished pursuant to this Agreement shall be subject to the
provisions of the Confidentiality Agreement, dated February&nbsp;16, 2006, between Parent and the
Company (the &#147;<B><I>Confidentiality Agreement</I></B>&#148;). The Company makes no representation or warranty as to
the accuracy of any information provided pursuant to Section&nbsp;8.2(a), and neither Parent nor Merger
Sub may rely on the accuracy of any such information, in each case other than as expressly set
forth in the Company&#146;s representations and warranties contained in Section&nbsp;5.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.3 <U>Merger With Shareholder Meeting</U>. If approval of the Company&#146;s shareholders is
required by applicable law in order to consummate the Merger other than pursuant to Section&nbsp;1110 of
the CGCL, the Company (under the direction of the Continuing Directors) shall duly call, give
notice of, convene and hold a special meeting of its shareholders (the &#147;<B><I>Company Shareholder
Meeting</I></B>&#148;) for the purpose of voting upon the approval of this Agreement. Subject to Section&nbsp;8.8,
the Company Board shall make the Company Recommendation and shall include such recommendation in
the Proxy Statement. Subject to Section&nbsp;8.8, the Company will use commercially reasonable efforts
to solicit from its shareholders proxies in favor of the approval of this Agreement and will take
all other action reasonably necessary or advisable to secure the vote or consent of its
shareholders required by the rules of NASDAQ or applicable law to obtain such approval.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.4 <U>Merger Without Shareholder Meeting</U>. In the event that Merger Sub shall acquire at
least ninety percent (90%) of the Fully Diluted Shares pursuant to the Offer or otherwise, each of
the parties hereto shall take all necessary and appropriate action to cause the Merger to become
effective as soon as practicable after such acquisition, without the Company Shareholder Meeting,
in accordance with Section&nbsp;1110 of the CGCL.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.5 <U>Further Actions</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Subject to the terms and conditions of this Agreement, each of Parent, Merger Sub and the
Company shall, and shall cause their respective Subsidiaries to, use their commercially reasonable
efforts (i)&nbsp;to take, or cause to be taken, all actions necessary, proper or advisable to comply
promptly with all legal requirements which may be imposed on such party or its Subsidiaries with
respect to the Offer and the Merger and, subject to the conditions set forth in Section&nbsp;9 hereof,
to consummate the transactions contemplated by this Agreement, (ii)&nbsp;to
</DIV>



<P align="center" style="font-size: 10pt">-40-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">resolve any instituted or
pending action or proceeding by any Governmental Entity of the types described in paragraph (a)&nbsp;of
<U>Annex I</U> to enable such Offer Conditions to be satisfied, and (iii)&nbsp;to obtain (and to
cooperate with the other party to obtain) any consent, authorization, order or approval of, or any
exemption by, any Governmental Entity and any other third Person which is
required to be obtained by the Company, Merger Sub or Parent or any of their respective
Subsidiaries in connection with the Offer and the Merger and the other transactions contemplated by
this Agreement. Without limiting the generality of the foregoing, each party shall, within ten
(10)&nbsp;Business Days after the execution of this Agreement, file all necessary documentation required
to obtain all requisite approvals or termination of applicable waiting periods for the transactions
contemplated hereby under the HSR Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Notwithstanding any other provision of this Agreement to the contrary, none of Parent, any
of its Subsidiaries or the Surviving Company, will be required (and the Company will not, without
the prior written consent of the Parent, agree, but will, if so directed by the Parent, agree,
effective after the Effective Time) to hold separate or divest any of their respective assets or
operations or enter into any consent decree or licensing or other arrangement with respect to any
of their assets or operations or to otherwise take or commit to take any action that limits its
freedom of action with respect to, or its ability to retain as of and after the Effective Time, any
businesses or assets of the Company, the Parent or any of their respective Affiliates.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Nothing in this Section&nbsp;8.5 shall be deemed to prevent the Company or the Company Board
from taking any action they are permitted or required to take under, and in compliance with,
Section&nbsp;8.8 or are required to take under applicable law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.6 <U>Employees; Employee Benefit Plans</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Parent shall, or shall cause the Surviving Company and its Subsidiaries to, (i)&nbsp;give those
employees who are, as of the Effective Time, employed by the Company and its Subsidiaries (the
&#147;<B><I>Continuing Employees</I></B>&#148;) full credit for purposes of eligibility, vesting and benefit accruals under
any employee benefit plans or arrangements maintained by Parent, the Surviving Company or any
Subsidiary of Parent or the Surviving Company (collectively, the &#147;<B><I>Parent Plans</I></B>&#148;) for such
Continuing Employees&#146; service with the Company or any of its Subsidiaries (or any predecessor
entity) to the same extent recognized by the Company and its Subsidiaries; (ii)&nbsp;waive all
limitations as to preexisting conditions, exclusions and waiting periods with respect to
participation and coverage requirements applicable to the Continuing Employees under any Parent
Plan that is a welfare benefit plan that such employees may be eligible to participate in after the
Effective Time; (iii)&nbsp;provide credit under any such welfare plan for any co-payments, deductibles
and out-of-pocket expenditures for the remainder of the coverage period during which any transfer
of coverage occurs; <I>provided</I>, <I>however</I>, that no such service shall be recognized to the extent such
recognition would result in the duplication of benefits; and (iv)&nbsp;honor in accordance with their
terms all employee benefit plans or arrangements maintained by the Company immediately prior to the
Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As soon as administratively practicable after the Effective Time but no later than
December&nbsp;31, 2006, and subject to the immediately following sentence, Parent shall, or shall cause
the Surviving Company and its Subsidiaries to, provide to the Continuing Employees
</DIV>



<P align="center" style="font-size: 10pt">-41-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"> compensation and
benefit arrangements that are no less favorable in the aggregate than
the compensation and benefit
arrangements that are provided to similarly situated employees of Parent. As soon as practicable
after the Effective Time, Parent shall, or shall cause the Surviving Company and its Subsidiaries
to, cause the Continuing Employees to commence participation in such Parent Plans as are provided
to similarly situated employees of Parent. From and after the
Effective Time, Parent and the Surviving Company shall keep in full force and effect, and
comply with the terms and conditions of, any agreement in effect as of the date of this Agreement
between or among the Company or any of its Subsidiaries and any of its or their employees relating
to severance pay or similar benefits.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The provisions of this Section&nbsp;8.6 are for the sole benefit of the parties to this
Agreement and nothing herein, expressed or implied, is intended or shall be construed to confer
upon or give to any Person (including for the avoidance of doubt any Continuing Employees, present
or former employees or directors, consultants or independent contractors of the Company or any of
its Subsidiaries, Parent or any of its Subsidiaries, or on or after the Effective Time, the
Surviving Company or any of its Subsidiaries), other than the parties hereto and their respective
permitted successors and assigns, any legal or equitable or other rights or remedies (with respect
to the matters provided for in this Section&nbsp;8.6) under or by reason of any provision of this
Agreement. Nothing contained in this Section&nbsp;8.6 or elsewhere in the Agreement shall be construed
to prevent, from and after the Effective Time, the termination of employment of any individual
Continuing Employee or, subject to the provisions of Section&nbsp;8.6(a), any change in the employee
benefits available to any Continuing Employee or the amendment or termination of any particular
Plan in accordance with its terms.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The Company shall, prior to the Effective Time, take all requisite action necessary to
terminate the Company&#146;s 401(k) Savings and Investment Plan, including notifying the participants
that the 401(k) Savings and Investment Plan has been terminated; provided, that immediately
following the Effective Time all Continuing Employees are permitted to participate in Parent&#146;s
401(k) Savings and Investment Plan.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.7 <U>Indemnification; Directors&#146; and Officers&#146; Insurance</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;From and after the Effective Time, each of Parent and the Surviving Company shall jointly
and severally: (i)&nbsp;indemnify and hold harmless each individual who served as a director or officer
of the Company or its Subsidiaries prior to the Effective Time (collectively, the &#147;<B><I>Indemnified
Parties</I></B>&#148;) to the fullest extent authorized or permitted by California law, as now or hereafter in
effect, in connection with any Claim (as defined below) and any judgments, fines (including excise
taxes), penalties and amounts paid in settlement (including all interest, assessments and other
charges paid or payable in connection with or in respect of such judgments, fines, penalties or
amounts paid in settlement) resulting therefrom; and (ii)&nbsp;promptly pay on behalf of or, within
thirty (30)&nbsp;days after any request for advancement, advance to each of the Indemnified Parties, to
the fullest extent authorized or permitted by California law, as now or hereafter in effect, any
Expenses (as defined below) incurred in defending, serving as a witness with respect to or
otherwise participating in any Claim in advance of the final disposition of such Claim, including
payment on behalf of or advancement to the Indemnified Party of any Expenses incurred by such
Indemnified Party in connection with enforcing any rights with respect to such indemnification
and/or advancement, in each case without the
</DIV>




<P align="center" style="font-size: 10pt">-42-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">requirement of any bond or other security, but in the
case of advancement of Expenses upon receipt of an undertaking, to the extent required by
applicable law, from such Indemnified Party to repay such advanced Expenses if it is determined by
a court of competent jurisdiction in a final order that such Indemnified Party was not entitled to
indemnification hereunder with respect to such Expenses. In the event any Claim is brought against
any Indemnified Party, Parent and the Surviving Company shall each use all commercially reasonable
efforts to assist in the vigorous defense of such matter, provided that neither Parent nor the
Surviving Company shall settle, compromise or consent to the entry of any judgment in any Claim
(and in which indemnification could be sought by such Indemnified Party hereunder) without the
prior written consent of such Indemnified Party if and to the extent the claimant seeks any
non-monetary relief from such Indemnified Party, which consent will not be unreasonably withheld.
The indemnification and advancement obligations of Parent and the Surviving Company pursuant to
this Section&nbsp;8.7(a) shall extend to acts or omissions occurring at or before the Effective Time and
any Claim relating thereto (including with respect to any acts or omissions occurring in connection
with the approval of this Agreement and the consummation of the transactions contemplated hereby
and any Claim relating thereto) and all rights to indemnification and advancement conferred
hereunder shall continue as to an individual who has ceased to be a director or officer of the
Company or its Subsidiaries prior to the Effective Time and shall inure to the benefit of such
individual&#146;s heirs, executors and personal and legal representatives. In connection with any
determination as to whether the Indemnified Parties are entitled to the benefits of this Section
8.7(a), the burden of proof shall be on Parent and the Surviving Company to establish that an
Indemnified Party is not so entitled. As used in this Section&nbsp;8.7(a), (A)&nbsp;the term &#147;<B><I>Claim</I></B>&#148; means
any threatened, asserted, pending or completed action, suit or proceeding, or any inquiry or
investigation, whether instituted by the Company, any Governmental Entity or any other party, that
any Indemnified Party in good faith believes might lead to the institution of any such action, suit
or proceeding, whether civil, criminal, administrative, investigative or other, including any
arbitration or other alternative dispute resolution mechanism, arising out of or pertaining to
matters that relate to such Indemnified Party&#146;s duties or service as a director, officer, trustee,
employee, agent, or fiduciary of the Company, any of its Subsidiaries, any employee benefit plan
maintained by any of the foregoing at or prior to the Effective Time and any other Person at the
request the Company or any of its Subsidiaries; and (B)&nbsp;the term &#147;<B><I>Expenses</I></B>&#148; means attorneys&#146; fees
and all other costs, expenses and obligations (including experts&#146; fees, travel expenses, court
costs, retainers, transcript fees, duplicating, printing and binding costs, as well as
telecommunications, postage and courier charges) paid or incurred in connection with investigating,
defending, being a witness in or participating in (including on appeal), or preparing to
investigate, defend, be a witness in or participate in, any Claim for which indemnification is
authorized pursuant to this Section&nbsp;8.7(a), including any action relating to a claim for
indemnification or advancement brought by an Indemnified Party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;From and after the Effective Time, Parent and the Surviving Company shall keep in full
force and effect, and comply with the terms and conditions of, any agreement in effect as of the
date of this Agreement between or among the Company or any of its Subsidiaries and any Indemnified
Party providing for the indemnification of such Indemnified Party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Without limiting any of the obligations under paragraph (a)&nbsp;of this Section&nbsp;8.7, Parent
agrees that all rights to indemnification and all limitations of liability existing in favor of the
Indemnified Parties as provided in the Company&#146;s Articles of Incorporation or Bylaws or
</DIV>



<P align="center" style="font-size: 10pt">-43-
</DIV>


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">in the corresponding constituent documents of any of the Company&#146;s Subsidiaries as in effect as of the date of this Agreement with respect to matters occurring on or prior to the Effective Time shall survive the Merger and shall continue in full force and effect thereafter, without any amendment thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;If Parent or the Surviving Company or any of its successors or assigns shall (i)
consolidate with or merge into any other Person and shall not be the continuing or surviving Person
of such consolidation or merger or (ii)&nbsp;transfer all or substantially all of its properties and
assets to any Person, then, in each such case, proper provisions shall be made so that the
successors and assigns of Parent and the Surviving Company, as the case may be (including Parent&#146;s
ultimate parent entity, if applicable), assume all of the obligations of Parent and the Surviving
Company set forth in this Section&nbsp;8.7.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;As of the Effective Time, Parent, the Surviving Company or the Company (with the election
being at Parent&#146;s option) shall have purchased and shall maintain in full force and effect for a
period of six (6)&nbsp;years after the Closing Date (or, if any Claim is asserted or made within such
six-year period, Parent shall ensure that such insurance remains in effect until final disposition
of such Claim) a directors&#146; and officers&#146; liability insurance policy or policies providing each
individual currently covered by the Company&#146;s directors&#146; and officers&#146; liability insurance coverage
for events occurring at or prior to the Effective Time (including acts or omissions relating to the
approval of this Agreement and consummation of the transactions contemplated hereby) that is no
less favorable than the Company&#146;s existing policy; <I>provided</I>, <I>however</I>, that Parent may substitute
therefor policies of at least the same coverage and amounts containing terms and conditions which
are in the aggregate no less advantageous to such directors and officers of the Company than the
terms and conditions of the existing directors&#146; and officers&#146; liability insurance policy of the
Company from reputable carriers having a rating comparable to the Company&#146;s current carrier.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;The provisions of this Section&nbsp;8.7 shall survive the consummation of the Merger and (i)
are intended to be for the benefit of, and shall be enforceable by, each Indemnified Party and his
or her heirs and representatives and (ii)&nbsp;are in addition to, and not in substitution for, any
other rights to indemnification or contribution that any such Person may have by contract or
otherwise. The obligations of Parent or the Surviving Company under this Section&nbsp;8.7 shall not be
terminated or modified in such a manner as to adversely affect the rights of any Indemnified Party
under this Section&nbsp;8.7 without the consent of such affected Indemnified Party. Parent shall cause
the Surviving Company to perform all of the obligations of the Surviving Company under this Section
8.7.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.8 <U>No Solicitation</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company shall, and shall cause each of its Subsidiaries, and shall cause their
respective officers, directors, representatives and agents (including any investment banker,
attorney or accountant retained by it or any of its Subsidiaries) (collectively, &#147;<B><I>Company
Representatives</I></B>&#148;) to, immediately cease any existing discussions or negotiations, if any, with any
Third Party that may be ongoing with respect to an Acquisition Proposal and will use its best
efforts to cause all Persons other than Parent who have been furnished with confidential
</DIV>


<P align="center" style="font-size: 10pt">-44-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">information regarding the Company in connection with the solicitation of or discussions regarding
an Acquisition Proposal within the 12&nbsp;months prior to the date hereof promptly to return or destroy
such information. The Company agrees not to, and to cause its Subsidiaries not
to, release any third party from the confidentiality and stand still provisions of any
agreement to which the Company or its Subsidiaries is a party or becomes a party, and will
immediately take all steps necessary to terminate any approval that may have heretofore been given
under any such provisions authorizing any Person to make an Acquisition Proposal, unless the
Company Board reasonably determines in good faith that such Acquisition Proposal is, or is
reasonably likely to be, a Superior Proposal. The Company shall not, and shall not authorize or
permit any of its Subsidiaries or any Company Representative to, directly or indirectly, (i)
solicit, initiate or knowingly encourage an Acquisition Proposal, (ii)&nbsp;furnish or disclose to any
Third Party non-public information with respect to an Acquisition Proposal, (iii)&nbsp;negotiate or
engage in substantive discussions with any Third Party with respect to an Acquisition Proposal or
(iv)&nbsp;enter into any agreement (whether or not binding) or agreement in principle with respect to an
Acquisition Proposal; <I>provided</I>, <I>however</I>, that at any time prior to the consummation of the Offer,
in response to a bona fide written Acquisition Proposal that was not solicited by the Company, its
Subsidiaries or any Company Representative and which the Company Board reasonably determines in
good faith, after consulting with its financial advisors and legal counsel, constitutes, or is
reasonably likely to constitute, a Superior Proposal, the Company may (A)&nbsp;furnish information with
respect to the Company and its Subsidiaries to the Person making such Acquisition Proposal (and its
officers, directors, employees, accountants, consultants, legal counsel, advisors, agents and other
representatives) and (B)&nbsp;participate in discussions or negotiations with, and provided draft
documents and agreements to, the Person making such Acquisition Proposal (and its officers,
directors, employees, accountants, consultants, legal counsel, advisors, agents and other
representatives) regarding such Acquisition Proposal, if (prior to furnishing such information to,
or entering into such discussions or negotiations with, such Person) the Company (A)&nbsp;provides
reasonable notice to Parent to the effect that it is furnishing information to, or entering into
discussions or negotiations with, such Person, (B)&nbsp;provides Parent with all information to be
provided to such Person which Parent has not previously been provided, and (C)&nbsp;receives from such
Person an executed confidentiality agreement reasonably satisfactory to the Company Board with
terms, as a whole, that are no less favorable to the Company than those contained in the
Confidentiality Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as set forth in this Section&nbsp;8.8(b), the Company Board shall not (i)&nbsp;withdraw or
modify, or propose to withdraw or modify, in a manner adverse to Parent, the Company
Recommendation, (ii)&nbsp;approve or recommend, or propose to approve or recommend, any Acquisition
Proposal or (iii)&nbsp;enter into any agreement (whether or not binding) or agreement in principle with
respect to any Acquisition Proposal (other than a confidentiality agreement referred to in Section
8.8(a)). Notwithstanding the foregoing, prior to consummation of the Offer, in response to the
receipt of an unsolicited Acquisition Proposal, if the Company Board (A)&nbsp;reasonably determines in
good faith after consultation with its legal counsel and financial advisors that such Acquisition
Proposal is a Superior Proposal and (B)&nbsp;determines in good faith after consultation with its legal
counsel that failure to take such action would be inconsistent with its fiduciary duties to the
shareholders of the Company under applicable law, then the Company Board may approve and recommend
such Superior Proposal and, in connection with such approval and recommendation, withdraw, or
modify or change in a manner adverse to Parent, the Company Recommendation (either, a &#147;<B><I>Company
Recommendation Change</I></B>&#148;);
</DIV>


<P align="center" style="font-size: 10pt">-45-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>provided</I>, <I>however</I>, that no Company Recommendation Change shall be valid or
effective until (i)&nbsp;the Company has provided written notice to Parent advising Parent that the
Company Board has received a Superior Proposal, specifying in writing all of the terms and
conditions of such
Superior Proposal and the identity of the Person making such Superior Proposal and, (ii)
Parent does not make, within three (3)&nbsp;Business Days after receipt of such notice from the Company,
an offer that the Company Board reasonably determines in good faith, after consultation with its
financial and legal advisors, is at least as favorable to the holders of Company Common Stock as
the Superior Proposal and during such three (3)&nbsp;Business Day period the Company reasonably
considers and discusses in good faith all proposals submitted by Parent and, without limiting the
foregoing, causes its financial advisors and legal advisors as requested by Parent to reasonably
consider and discuss with Parent and its representatives such proposals in good faith. In the
event that the Company enters into a definitive agreement with a Third Party with respect to a
Superior Proposal and in connection therewith this Agreement is terminated, then, notwithstanding
anything to the contrary in the standstill provisions of the Confidentiality Agreement, Parent
shall be entitled to present an Acquisition Proposal to the Company Board (it being understood that
except as modified hereby such standstill provisions shall remain in full force and effect).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Nothing contained in this Agreement shall prohibit the Company or the Company Board from
(i)&nbsp;taking and disclosing to the shareholders of the Company a position contemplated by Rule&nbsp;14e-2
promulgated under the Exchange Act or (ii)&nbsp;making any disclosure to the shareholders of the Company
if the Company Board determines in good faith that such disclosure is required by applicable law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;As used in this Agreement:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&#147;<B><I>Acquisition Proposal</I></B>&#148; means any inquiry, proposal or offer relating to (i)&nbsp;the
acquisition of 20% or more of the outstanding shares of capital stock or any other voting
securities of the Company by any Third Party, (ii)&nbsp;a merger, consolidation, business combination,
reorganization, share exchange, sale of assets, recapitalization, liquidation, dissolution or
similar transaction which would result in any Third Party acquiring 20% or more of the fair market
value of the assets of the Company and its Subsidiaries, taken as a whole (including capital stock
of Subsidiaries of the Company), (iii)&nbsp;any other transaction which would result in a Third Party
acquiring 20% or more of the fair market value of the assets of the Company and its Subsidiaries,
taken as a whole (including capital stock of Subsidiaries of the Company), immediately prior to
such transaction (whether by purchase of assets, acquisition of stock of a Subsidiary or
otherwise), (iv)&nbsp;any combination of the foregoing or (v)&nbsp;any other transaction that is conditioned
or predicated on the Merger not being completed in accordance with the terms of this Agreement or
would reasonably be expected to result in the Merger not being so completed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) &#147;<B><I>Superior Proposal</I></B>&#148; means an Acquisition Proposal (with all of the percentages included
in the definition of Acquisition Proposal increased to 75%) the terms of which the Company Board
determines in good faith (after consultation with its financial advisors and legal counsel), taking
into account, among other things, the legal, financial and regulatory aspects of such Acquisition
Proposal and the Third Party making such Acquisition Proposal, whether the acquiring party is
capable of consummating the Acquisition Proposal on the terms
</DIV>

<P align="center" style="font-size: 10pt">-46-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">proposed, and whether the Acquisition
Proposal is subject to any financing contingency, would, if consummated, be more favorable from a
financial point of view to the holders of Company Common Stock than those set forth in this
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.9 <U>Section&nbsp;16 Matters</U>.
Prior to the Effective Time, the Board of Directors of the
Company shall take all such steps as may be required and permitted to cause the transactions
contemplated by this Agreement, including any dispositions of shares of Company Common Stock
(including derivative securities with respect to such Company Common Stock) by each individual who
is or will be subject to the reporting requirements of Section 16(a) of the Exchange Act with
respect to the Company, to be exempt under Rule&nbsp;16b-3 promulgated under the Exchange Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.10 <U>InnovaQuartz Stock Purchase Agreement</U>.
Parent hereby agrees and acknowledges
that following the Effective Time, the Surviving Company shall assume (i)&nbsp;any and all of the
Company&#146;s payments obligations specified in Sections&nbsp;1.3 and 1.4 of that certain Stock Purchase
Agreement dated as of April&nbsp;30, 2006 by and between the Company, InnovaQuartz Incorporated, an
Arizona corporation (&#147;<B><I>InnovaQuartz</I></B>&#148;), and the stockholders of InnovaQuartz (the &#147;<B><I>InnovaQuartz Stock
Purchase Agreement</I></B>&#148;), and (ii)&nbsp;any and all of the Company&#146;s operational covenants specified in
Section&nbsp;6.10 of the InnovaQuartz Stock Purchase Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.11 <U>Notification of Certain Matters</U>.
The Company will give prompt written notice to
the Parent, and the Parent will give prompt written notice to the Company, of any material failure
of the Company or Parent or Merger Sub, as the case may be, to comply with or satisfy any covenant,
condition or agreement to be complied with or satisfied by it hereunder; <I>provided, however</I>, that
the delivery of any notice pursuant to this Section&nbsp;8.11 will not limit or otherwise affect the
remedies available hereunder to the party receiving such notice; <I>provided</I>, <I>further</I>, the failure to
deliver any such notice shall not be considered in determining whether the condition set forth in
paragraph (c)&nbsp;of <U>Annex I</U> exists.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">9. CONDITIONS PRECEDENT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions to Each Party&#146;s Obligation to Effect the Merger</U>. The respective
obligations of each party to effect the Merger shall be subject to the satisfaction at or prior to
the Effective Time of the following conditions:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Shareholder Approval</U>. If required by applicable law, the Agreement of Merger
shall have been approved by the Company Required Vote.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>HSR Compliance</U>. The applicable waiting period under the HSR Act shall have
expired or been terminated.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>No Injunctions or Restraints; Illegality</U>. No order, injunction, statute, rule,
regulation or decree shall have been issued, enacted, entered, promulgated or enforced by a
Governmental Entity that prohibits or makes illegal the consummation of the Merger.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Purchase of Shares</U>. Merger Sub shall have purchased the Shares validly tendered
pursuant to the Offer in an amount sufficient to meet the Minimum Condition or, if applicable
pursuant to the provisions of this Agreement, the Option Exercise Minimum
</DIV>


<P align="center" style="font-size: 10pt">-47-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Condition or the Revised
Minimum Condition, provided that no party shall be entitled to invoke this condition if, in breach
of its obligations under this Agreement, it shall have been the cause of
the failure of Merger Sub to purchase pursuant to the Offer, the Shares validly tendered and
not withdrawn.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">10. TERMINATION AND AMENDMENT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.1 <U>Termination</U>. This Agreement may be terminated and the Offer, the Merger and the
transactions contemplated hereby may be abandoned at any time prior to the Effective Time by action
taken or authorized by the Board of Directors of the terminating party or parties, notwithstanding
any requisite approval of this Agreement by the shareholders of the Company, and whether before or
after the shareholders of the Company have approved this Agreement at the Company Shareholder
Meeting, as follows (the date of any such termination, the &#147;<B><I>Termination Date</I></B>&#148;):
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;by mutual consent of Parent and the Company in a written instrument, if the Board of
Directors of each so determines;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;by either Parent or the Company if any Governmental Entity of competent jurisdiction shall
have issued a final nonappealable order which has the effect of making consummation of the Offer or
the Merger illegal or otherwise preventing or prohibiting consummation of the Offer or the Merger;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;by either Parent or the Company if the Offer has not been consummated on or before
December&nbsp;31, 2006; <I>provided, however</I>, that the right to terminate this Agreement under this Section
10.1(c) shall not be available to a party whose failure to fulfill any obligation under this
Agreement materially contributed to the failure of the Offer to be consummated on or before such
date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;by either Parent or the Company if the Offer terminates or expires in accordance with its
terms, after giving effect to the rights and obligations of the parties set forth in Section&nbsp;1.1(d)
and Section&nbsp;1.1(e), without Merger Sub having accepted for payment any Shares pursuant to the Offer
due to its failure to achieve the Revised Minimum Condition, except that the right to terminate
this Agreement under this Section&nbsp;10.1(d) will not be available to any party whose failure to
perform any obligation under this Agreement has been the proximate cause of, or resulted in, such
failure to achieve the Revised Minimum Condition;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;by Parent if it is not in material breach of this Agreement and if (i)&nbsp;there has been a
breach on the part of the Company of any of its covenants or agreements herein such that the
condition set forth in paragraph (b)&nbsp;of <U>Annex I</U> exists or (ii)&nbsp;any of the representations
and warranties of the Company herein are or become untrue or incorrect such that the condition set
forth in paragraph (c)&nbsp;of <U>Annex I</U> exists (in each case, after giving effect to the cure
periods specified therein);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;by the Company if it is not in material breach of this Agreement, and if (i)&nbsp;the
representations and warranties of Parent and Merger Sub in Section&nbsp;6.6 are or become untrue or
inaccurate or (ii)&nbsp;any of the representations and warranties of Parent and Merger Sub herein, other
</DIV>
<P align="center" style="font-size: 10pt">-48-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">than those set forth in Section&nbsp;6.6, are or become untrue or inaccurate, or (iii)&nbsp;there has
 been a
breach on the part of Parent or Merger Sub of any of their respective covenants or agreements
herein, and, in the case of clause (ii)&nbsp;and (iii)&nbsp;only, (A)&nbsp;such breach has not been, or
cannot be, cured in all material respects within thirty (30)&nbsp;Business Days after written
notice to Parent and Merger Sub, or (B)&nbsp;without regard to any qualification or reference to
materiality or Parent Material Adverse Effect set forth in such representations and warranties,
such inaccuracy or breach would, individually or in the aggregate, have a Parent Material Adverse
Effect;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;by Parent (i)&nbsp;if the Company breaches in any material respect any of its obligations under
Section&nbsp;8.8, (ii)&nbsp;if the Company Board shall have effected a Company Recommendation Change, or
(iii)&nbsp;the Company shall have failed to include in the Proxy Statement distributed to the Company&#146;s
shareholders, if any, its recommendation that shareholders approve this Agreement and the Merger;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;by the Company (i)&nbsp;if the Company Board shall have effected a Company Recommendation
Change prior to the consummation of the Offer and the Company is not concurrently in material
breach of its obligations under this Agreement and has materially complied with its obligations
under Section&nbsp;8.8, or (ii)&nbsp;if Parent or Merger Sub shall have failed to commence the Offer in
accordance with Section&nbsp;1.1(a); <U>provided</U>, <U>however</U>, the Company may not terminate
this Agreement pursuant to this Section&nbsp;10.1(h)(ii) if such failure to have commenced the Offer
shall have been caused by the Company&#146;s failure to perform in all material respects its obligations
under this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.2 <U>Effect of Termination</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;In the event of termination of this Agreement by either Parent or the Company as provided
in Section&nbsp;10.1, this Agreement shall forthwith become void and have no effect, and none of Parent,
Merger Sub, the Company, any of their respective Subsidiaries or any of the officers or directors
of any of them shall have any liability of any nature whatsoever hereunder, or in connection with
the transactions contemplated hereby; <I>provided, however</I>, that (i)&nbsp;Section&nbsp;8.2(b), the last sentence
of Section&nbsp;8.8(b), Section&nbsp;10.2 and Section&nbsp;11 shall survive any termination of this Agreement and
(ii)&nbsp;notwithstanding anything to the contrary contained in this Agreement, neither Parent, Merger
Sub nor the Company shall be relieved or released from any liabilities or damages arising out of
its willful and material breach of this Agreement; <I>provided, however, </I>that receipt of the
Termination Fee (as defined below) as provided herein shall be the sole and exclusive remedy of
Parent and Merger Sub under circumstances where the Termination Fee is payable by the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company shall pay Parent, by wire transfer of immediately available funds, the sum of
$25,000,000 (the &#147;<B><I>Termination Fee</I></B>&#148;) if this Agreement is terminated as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;if this Agreement is terminated pursuant to Sections&nbsp;10.1(g) or 10.1(h)(i), then (so long
as neither Parent nor Merger Sub was in material breach of this Agreement) the Company shall pay
the Termination Fee to Parent on the second Business Day after the date of
</DIV>

<P align="center" style="font-size: 10pt">-49-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;termination;
or (ii)&nbsp;if (A)&nbsp;this Agreement is terminated by either Parent or the Company pursuant to Sections
10.1(c), 10.1(d) or 10.1(e), (B)&nbsp;in the case of a termination pursuant to Sections&nbsp;10.1(c) and
10.1(d) only, prior to the Termination Date there shall have
been an Acquisition Proposal, and (C)&nbsp;within twelve (12)&nbsp;months of the Termination Date, the
Company enters into a definitive agreement with a Third Party with respect to an Acquisition
Proposal or any Acquisition Proposal is consummated by such Third Party, then (so long as neither
Parent nor Merger Sub was not in material breach of this Agreement) the Company shall pay, or cause
to be paid to, Parent the Termination Fee upon consummation of such Acquisition Proposal.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Any amount that becomes payable pursuant to Section&nbsp;10.2(b) shall be paid by wire transfer
of immediately available funds to an account designated by Parent. For the avoidance of doubt, in
no event shall the Company be obligated to pay the Termination Fee on more than one occasion.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The Company and Parent agree that the agreements contained in Section&nbsp;10.2(b) are an
integral part of the transactions contemplated by this Agreement, that without such agreements
Parent would not have entered into this Agreement, and that the amount of the Termination Fee does
not constitute a penalty.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.3 <U>Amendment</U>. Subject to compliance with applicable law, this Agreement may be
amended by the parties hereto, by action taken or authorized by their respective boards of
directors, at any time before the Effective Time; <I>provided</I>, <I>however</I>, that after receipt of the
Company Required Vote, there may not be any amendment of this Agreement which, by applicable law or
in accordance with the rules of any relevant stock exchange, requires further approval of the
Company&#146;s shareholders. This Agreement may not be amended except by an instrument in writing signed
on behalf of each of the parties hereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.4 <U>Extension; Waiver</U>. At any time prior to the Effective Time, the parties hereto
may, to the extent legally allowed, (a)&nbsp;extend the time for the performance of any of the
obligations or other acts of the other parties hereto, (b)&nbsp;waive any inaccuracies in the
representations and warranties contained herein or in any document delivered pursuant hereto and
(c)&nbsp;waive compliance with any of the agreements or conditions contained herein; <I>provided</I>, <I>however</I>,
that, after receipt of the Company Required Vote, there may not be any extension or waiver of this
Agreement which decreases the Merger consideration or which adversely affects the rights of the
Company&#146;s shareholders hereunder without the approval of such shareholders. Any agreement on the
part of a party hereto to any such extension or waiver shall be valid only if set forth in a
written instrument signed on behalf of such party, but such extension or waiver or failure to
insist on strict compliance with an obligation, covenant, agreement or condition shall not operate
as a waiver of, or estoppel with respect to, any subsequent or other failure.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">11. GENERAL PROVISIONS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.1 <U>Nonsurvival of Representations, Warranties and Agreements</U>. None of the
representations, warranties, covenants and agreements in this Agreement or in any instrument
delivered pursuant to this Agreement shall survive the Effective Time, except for those
</DIV>

<P align="center" style="font-size: 10pt">-50-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">covenants
and agreements contained herein and therein which by their terms apply in whole or in part after
the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.2 <U>Expenses</U>. Except as provided in Section&nbsp;10.2 hereof, all costs and expenses
incurred in connection with this Agreement and the transactions contemplated hereby shall be paid
by the party incurring such expense, except that each of the Company and Parent shall bear and pay
one-half of the costs and expenses incurred in connection with the filing, printing and mailing of
the Offer Documents, Schedule&nbsp;14D-9 and the Proxy Statement (including any SEC filing fees) and any
filing fees required to be paid under the HSR Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.3 <U>Notices</U>. All notices and other communications hereunder shall be in writing and
shall be deemed given if delivered personally, telecopied (with confirmation) or delivered by an
overnight courier (with confirmation) to the parties at the following addresses (or at such other
address for a party as shall be specified by like notice):
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;if to Parent or Merger Sub, to:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 8%">American Medical Systems Holdings, Inc.<br>
10700 Bren Road West<br>
Minnetonka, Minnesota 55343<br>
Attention: Chief Executive Officer<br>
Facsimile: (952)&nbsp;930-6695
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with a copy to:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 8%">Oppenheimer Wolff &#038; Donnelly LLP<br>
Plaza VII<br>
45 South Seventh Street, Suite&nbsp;3300<br>
Minneapolis, MN 55402<br>
Attention: Thomas A. Letscher, Esq.<br>
Facsimile: (612)&nbsp;607-7100
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If to the Company, to:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 8%">Laserscope<br>
3070 Orchard Drive<br>
San Jose, CA 95134-2011<br>
Attention: Chief Executive Officer<br>
Facsimile: (408)&nbsp;943-9630
</DIV>

<P align="center" style="font-size: 10pt">-51-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">with a copy to:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">Orrick, Herrington &#038; Sutcliffe LLP<br>
The Orrick Building<br>
405 Howard Street<br>
San Francisco, CA 94105<br>
Attention: Richard Vernon Smith, Esq.
<BR>
Facsimile: (415)&nbsp;773-5759
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.4 <U>Interpretation; Construction</U>. The words &#147;hereof,&#148; &#147;herein&#148; and &#147;hereunder&#148; and
words of similar import when used in this Agreement shall refer to this Agreement as a whole and
the schedules hereto and not to any particular provision of this Agreement, and Section references
are to this Agreement unless otherwise specified. Whenever the words &#147;include,&#148; &#147;includes&#148; or
&#147;including&#148; are used in this Agreement, they shall be deemed to be followed by the words &#147;without
limitation.&#148; Unless the context otherwise requires, &#147;or&#148; is not exclusive. The definitions
contained in this Agreement are applicable to the singular as well as the plural forms of such
terms and to the masculine as well as to the feminine and neuter genders of such term. The table
of contents and headings contained in this Agreement are for reference purposes only and shall not
affect in any way the meaning or interpretation of this Agreement. No provision of this Agreement
shall be construed to require the Company, Merger Sub, Parent or any of their respective officers,
directors, Subsidiaries or Affiliates to take any action which would violate or conflict with any
applicable law (whether statutory or common), rule or regulation. This Agreement shall be construed
without regard to any presumption or interpretation against the party drafting or causing any
instrument to be drafted. All schedules accompanying this Agreement and all information
specifically referenced in any such schedule form an integral part of this Agreement, and
references to this Agreement include reference to them.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.5 <U>Counterparts; Facsimile</U>. This Agreement may be executed in counterparts, all of
which shall be considered one and the same agreement and shall become effective when counterparts
have been signed by each of the parties and delivered to the other parties, it being understood
that all parties need not sign the same counterpart. Signatures transmitted by facsimile shall be
accepted as originals for all purposes of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.6 <U>Entire Agreement</U>. This Agreement (together with the documents, schedules and the
instruments referred to herein or delivered herewith) constitutes the entire agreement and
supersedes all prior agreements and understandings, both written and oral, among the parties with
respect to the subject matter hereof, other than the Confidentiality Agreement, which shall survive
the execution and delivery of this Agreement and any termination of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.7 <U>Governing Law; Venue</U>. This Agreement shall be governed and construed in
accordance with the laws of the State of California, without regard to any applicable conflicts of
law provisions (except to the extent that mandatory provisions of federal law). Each of the
parties hereto irrevocably submit to the exclusive jurisdiction and venue of the courts of the
State of California or of the United States of America, in each located in the County of Santa
Clara, California, for the purpose of any suit, action or other proceeding arising out of this
Agreement, or any of the agreements or transactions contemplated hereby, which is brought by or
against any other party hereto and hereby irrevocably agree
</DIV>

<P align="center" style="font-size: 10pt">-52-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(a)&nbsp;that all claims in respect of any
such suit, action or proceeding may be heard and determined in any such court and (b)&nbsp;not to
commence any action suit or proceeding relating to this Agreement other than in such court. Each
party hereto irrevocably and unconditionally waives and agrees not to assert in any such suit, action or proceeding, in each case, to the fullest extent permitted by applicable law, (i)&nbsp;any
objection to the laying of venue of any such suit, action or proceeding brought in any such court,
(ii)&nbsp;any claim that such party is not personally subject to the jurisdiction of any such court, and
(iii)&nbsp;any claim that any such suit, action or proceeding is brought in an inconvenient forum. Each
party hereto agrees that service of any process, summons, notice or document by U.S. registered
mail addressed to such party shall be effective service of process for any action, suit or
proceeding
brought against such party in any such court. Each party hereto agrees that a final judgment
in any such suit, action or proceeding brought in any such court shall be conclusive and binding
upon such party and may be enforced in any other courts to whose jurisdiction such party is or may
be subject, by suit upon such judgment.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.8 <U>Severability</U>. Any term or provision of this Agreement which is determined by a
court of competent jurisdiction to be invalid or unenforceable in any jurisdiction shall, as to
that jurisdiction, be ineffective to the extent of such invalidity or unenforceability without
rendering invalid or unenforceable the remaining terms and provisions of this Agreement or
affecting the validity or enforceability of any of the terms or provisions of this Agreement in any
other jurisdiction, and if any provision of this Agreement is determined to be so broad as to be
unenforceable, the provision shall be interpreted to be only so broad as is enforceable, in all
cases so long as neither the economic nor legal substance of the transactions contemplated hereby
is affected in any manner materially adverse to any party or its shareholders. Upon any such
determination, the parties shall negotiate in good faith in an effort to agree upon a suitable and
equitable substitute provision to effect the original intent of the parties.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.9 <U>Publicity</U>. Parent, Merger Sub and the Company shall consult with each other
before issuing any press release with respect to the Offer, the Merger or this Agreement and shall
not issue any such press release or make any such public statement without the prior consent of the
other party, which shall not be unreasonably withheld or delayed; <I>provided</I>, <I>however</I>, that a party
may, without the prior consent of the other party (but after prior consultation, to the extent
practicable in the circumstances) issue such press release or make such public statement or SEC
filing as may upon the advice of outside counsel be required by law or the rules and regulations of
any applicable stock exchange (including the NASDAQ National Market). The parties have agreed upon
the form of a joint press release announcing the Offer, the Merger and the execution of this
Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.10 <U>Assignment; Third Party Beneficiaries</U>. Neither this Agreement nor any of the
rights, interests or obligations of any party hereunder shall be assigned by any of the parties
hereto (whether by operation of law or otherwise) without the prior written consent of the other
party. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit
of and be enforceable by the parties and their respective successors and permitted assigns. Except
as otherwise specifically provided in Section&nbsp;8.5 and Section&nbsp;8.6, this Agreement (including the
documents and instruments referred to herein) is not intended to confer upon any Person other than
the parties hereto any rights or remedies hereunder.
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">&#091;Remainder of Page Left Blank Intentionally&#093;

</DIV>

<P align="center" style="font-size: 10pt">-53-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, Parent, Merger Sub and the Company have caused this Agreement to be
executed by their respective officers hereunto duly authorized as of the date first above written.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" nowrap>By:&nbsp;</TD>
    <TD colspan="2"><DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV></TD>

    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" colspan="2">Name:
</TD>

    <TD align="left" valign="top">
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" colspan="2">Title:</TD>

    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">KERMIT MERGER CORP.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:</TD>
    <TD colspan="2"><DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" colspan="2">Name:
</TD>

    <TD align="left" valign="top">
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" colspan="2">Title:</TD>

    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">LASERSCOPE</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:</TD>
    <TD colspan="2"><DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" colspan="2">Name:
</TD>

    <TD align="left" valign="top">
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" colspan="2">Title:</TD>

    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURE PAGE TO AGREEMENT AND PLAN OF MERGER</B>
</DIV>


<P align="center" style="font-size: 10pt">
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U><B>ANNEX I</B></U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>CONDITIONS TO THE OFFER</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any other provision of the Offer, subject to the terms of this Agreement,
Merger Sub shall not be required to accept for payment (subject to any applicable rules and
regulations of the SEC, including Rule&nbsp;14e-1(c) under the Exchange Act (relating to Merger Sub&#146;s
obligation to pay for or return tendered Shares after the termination or withdrawal of the Offer))
any Shares tendered if, by the expiration of the Offer (as it may be extended in accordance with
the requirements of Section&nbsp;1.1(d)), (1)&nbsp;the Minimum Condition or, if applicable pursuant to the
provisions of this Agreement, the Option Exercise Minimum Condition or the Revised Minimum
Condition, shall not have been satisfied, (2)&nbsp;the applicable waiting period under the HSR Act and
any other applicable antitrust laws shall not have expired or been terminated, or (3)&nbsp;at any time
on or after the date of this Agreement and prior to the acceptance for payment of Shares pursuant
to the Offer, any of the following conditions exist:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) there shall be any action taken, or any statute, rule, regulation, injunction,
order or decree proposed, enacted, enforced, promulgated, issued or deemed applicable to
this Agreement, the Shareholder Agreements, the Offer or the Merger, by any Governmental
Entity (other than in connection with any action or proceeding initiated by or on behalf of
any shareholder of the Company) that has resulted in, or is reasonably likely to result in,
directly or indirectly, (i)&nbsp;the making of the Offer, the acceptance for payment of some of
or all the Shares by Parent or Merger Sub or the consummation by Parent or Merger Sub of the
Merger becoming illegal or exposing Parent or Merger Sub to liability for material damages,
(ii)&nbsp;any restraint or prohibition on Parent&#146;s or Merger Sub&#146;s ownership or operation (or
that of their respective Subsidiaries or Affiliates) of all or any portion of the business
or assets of the Company and its Subsidiaries, taken as a whole, or of Parent and its
Subsidiaries, taken as a whole, or compelling Parent or any of its Subsidiaries or
Affiliates to dispose of or hold separate all or any portion of the business or assets of
the Company and its Subsidiaries, taken as a whole, or of Parent and its Subsidiaries, taken
as a whole, (iii)&nbsp;the imposition of limitations on the ability of Parent or any of its
Subsidiaries or Affiliates effectively to exercise full rights of ownership of the Shares,
including, without limitation, the right to vote any Shares acquired or owned by Parent or
any of its Subsidiaries or Affiliates on all matters properly presented to the Company&#146;s
shareholders or (iv)&nbsp;the imposition of an obligation of Parent or any of its Subsidiaries or
Affiliates to divest any of the Shares; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the Company shall have failed to perform in any material respect, or to comply in
any material respect with, its covenants or agreements in this Agreement, except where the
failure to so perform or comply (i)&nbsp;is curable and has been cured within thirty (30)
Business Days after receipt of written notice of such failure from Parent, or (ii)
individually or in the aggregate, would not have a Company Material Adverse Effect; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) any representation and warranty of the Company in this Agreement is not true and
correct (except as to any such representation or
</DIV>

<P align="center" style="font-size: 10pt">I-1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">warranty
that speaks as of a specific date, which must be true and correct only as of such specific date), except
where the failure to be so true and correct (i)&nbsp;is curable and has been cured within thirty
(30)&nbsp;Business Days after receipt of written notice of such failure from Parent, or (ii)
without regard to any qualification or reference to materiality or Company Material Adverse
Effect set forth in such representation and warranty, would not, individually or in the
aggregate, have a Company Material Adverse Effect; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Parent shall have failed to receive a certificate executed on behalf of the Company
by the Chief Executive Officer and the Chief Financial Officer of the Company (in their
respective capacities as officers of the Company), dated as of the scheduled expiration date
of the Offer, to the effect that the conditions set forth in paragraphs (b)&nbsp;and (c)&nbsp;of this
<U>Annex I </U>have not occurred; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) the Agreement shall have been terminated in accordance with its terms; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) the Company Board (or any committee thereof) shall have made a Company
Recommendation Change; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) the Company shall have entered into an agreement or agreement in principle (other
than a confidentiality agreement permitted by Section&nbsp;8.8 of this Agreement) with respect to
any Acquisition Proposal; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) a Company Material Adverse Effect shall have occurred subsequent to March&nbsp;31, 2006
and continue to exist.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The foregoing conditions are for the sole benefit of Parent and Merger Sub and may be asserted
by Parent regardless of the circumstances (including any action or omission by Parent or Merger
Sub) giving rise to any such condition or (other than the Minimum Condition) may, subject to the
terms of this Agreement, be waived by Parent and Merger Sub in their reasonable discretion in whole
at any time or in part from time to time. The failure by Parent or Merger Sub at any time to
exercise its rights under any of the foregoing conditions shall not be deemed a waiver of any such
right; the waiver of any such right with respect to particular facts and circumstances shall not be
deemed a waiver with respect to any other facts and circumstances, and each such right shall be
deemed an ongoing right which may be asserted at any time or from time to time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capitalized terms used but not defined in this <U>Annex I</U> shall have the meanings
ascribed to such terms in the Agreement to which it is annexed, except that the term &#147;Agreement&#148;
shall be deemed to refer to the Agreement to which this <U>Annex I</U> is appended.
</DIV>


<P align="center" style="font-size: 10pt">I-2
</DIV>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
